|
|
Books
1. Jeste DV and Wyatt RJ:
Understanding and Treating Tardive Dyskinesia. New York: Guilford
Press Inc. 1982 (363 pages).
2. Jeste DV and Wyatt RJ (eds): Neuropsychiatric Movement Disorders.
Washington, DC: American Psychiatric Press. 1984 (150 pages).
3. Jeste DV (ed): Neuropsychiatric Dementias: Current Perspectives.
Washington, DC: American Psychiatric Press. 1986 (143 pages).
4. Jeste DV and Zisook S (eds.): Psychosis and Depression in the
Elderly. Psychiatric Clinics of North America. Philadelphia: WB
Saunders Co. Vol. 11, Number 1, March, 1988 (286 pages).
5. Kane JM, Jeste DV, Barnes TRE, Casey DE, Cole JO, Davis JM,
Gualtieri CT, Schooler NR, Sprague R and Wettstein RM: Tardive
Dyskinesia: A Task Force Report of the American Psychiatric
Association. Washington, DC: American Psychiatric Association, 1992
(282 pages).
6. Yassa R, Nair NPV, and Jeste DV (eds.): Neuroleptic-Induced
Movement Disorders. New York: Cambridge University Press, 1997 (494
pages).
7. Jeste DV and Friedman J (eds.): Psychiatry for Neurologists.
Totowa, New Jersey: Humana Press, 2006 (427 pages).
8. Sunderland T, Jeste DV, Baiyewu O, Sirovatka PJ, and Regier DA (eds):
Diagnostic Issues in Dementia: Advancing the Research Agenda for
DSM-V. Arlington, VA: American Psychiatric Association, 2007 (145
pages).
9. Mueser K and Jeste DV (eds): The Clinical Handbook of
Schizophrenia. New York: Guilford Press (in press, 2008).
Journal Articles
1. Shah LP and Jeste DV: Hysteria and
its management. Indian Journal of Medical Sciences 23:273 282, 1969.
2. Bagadia VN, Jeste DV, Chawla R, Saraf KR and Shah LP:
Trifuperidol in schizophrenia: A clinical trial. Indian Journal of
Psychiatry 14:31 37, 1972.
3. Doongaji DR, Jeste DV, Saoji NJ, Kane PV and Ravindranath, S:
Unilateral versus bilateral ECT in schizophrenia. British Journal of
Psychiatry 123:73 80, 1973.
4. Vahia NS, Doongaji DR, Jeste DV, Ravindranath S, Kapoor SM and
Ardhapurkar I: Psychophysiological therapy based on the concepts of
Patanjali: A new approach to the treatment of neurotic and
psychosomatic disorders. American Journal of Psychotherapy 27: 557
565, 1973.
5. Vahia NS, Doongaji DR, Jeste DV, Kapoor SM, Ardhapurkar I and
Ravindranath S: Further experience with the therapy based upon
concepts of Patanjali in the treatment of psychiatric disorders.
Indian Journal of Psychiatry 15:32 37, 1973.
6. Bagadia VN, Jeste DV, Dave KP, Doshi SV and Shah LP: Depression:
(a) A study of demography factors in 233 cases. Indian Journal of
Psychiatry 15:209 216, 1973. (b) Family and Psychodynamic study of
233 cases. Indian Journal of Psychiatry 15:217 223, 1973. (c) A
clinical study of 233 cases. Indian Journal of Psychiatry 15:224
230, 1973.
7. Jeste DV, Vahia NS and Ravindranath S: A comparative study of
doxepin and placebo in depression. Indian Journal of Medical
Sciences 27:759 764, 1973.
8. Jeste DV, Sule SM, Vahia VN and Kulkarni VM: Psychiatry and
psychological disturbances of pregnancy. Indian Practitioner 26:357
362, 1973.
9. Bagadia VN, Jeste DV, Charegaonkar AS, Pradham PV and Shah LP:
Psychological study of 180 cases of epilepsy. Indian Journal of
Psychiatry 15:391 401, 1973.
10. Jeste DV, Sule SM, Apte JS and Vahia NS: Gilles de la Tourette's
disease: Multiple vocal and motor tics. Indian Journal of Pediatrics
40:435 438, 1973.
11. Jeste DV, Doongaji DR and Mistry PP: Reflex (sensory
precipitation) epilepsy: Review and case report. Journal of
Postgraduate Medicine 19:90 94, 1973.
12. Vahia NS, Doongaji DR and Jeste DV: Twenty five years of
psychiatry in a teaching general hospital (in India). Indian Journal
of Psychiatry 16:221 228, 1974.
13. Vahia VN and Jeste DV: Recent advances in treatment of
psychiatric disorders. The Indian Practitioner 27:47 54, 1974.
14. Doongaji DR, Jeste, DV, Saoji NJ and Lotlikar KD: Multiple
choice examination in psychiatry: A comparative study with other
systems of examination. Journal of Postgraduate Medicine 21: 135
143, 1975.
15. Doongaji DR, Sheth AS, Ramesh SP, Jeste DV and Ravindranath, P:
A double blind study of pimozide versus chlordiazepoxide in anxiety
neuroses. Acta Psychiatrica Belgica 76:632 643, 1976.
16. Jeste DV, Olgiati SV and Ghali AY: Masking of tardive dyskinesia
with four times a day administration of chlorpromazine. Diseases of
Nervous System 38:755 758, 1977.
17. Jeste DV, Potkin SG, Sinha S, Feder SL and Wyatt RJ: Tardive
dyskinesia reversible and persistent. Archives of General Psychiatry
36:585 590, 1979.
18. Jeste DV, and Wyatt RJ: In search of treatment for tardive
dyskinesia A review of literature. Schizophrenia Bulletin 5:251 293,
1979.
19. Jeste DV, Gillin JC and Wyatt RJ: Serendipity in biological
psychiatry A myth? Archives of General Psychiatry 36:1173 1178,
1979.
20. Jeste DV, Perlow M, Wyatt RJ and Stoff DM: Behavioral effects of
amfonelic acid in rats Comparison with amphetamine and apomorphine.
Communications in Psychopharmacology 3:41 47, 1979.
21. Jeste DV, Stoff DM, Potkin SG and Wyatt RJ: Amphetamine
sensitivity and tardive dyskinesia: An animal model. Indian Journal
of Psychiatry 21:362 369, 1979.
22. Jeste DV and Wyatt RJ: Tardive dyskinesia: The syndrome.
Psychiatry Annals 10:16 25, 1980.
23. Jeste DV and Wyatt RJ: Tardive dyskinesia: A review of treatment
possibilities and their effectiveness. Psychiatry Annals 10:26 38,
1980.
24. Jeste DV and Wyatt RJ: Guidelines for the use of neuroleptics in
clinical practice. Psychiatry Annals 10:39 52, 1980.
25. Jeste DV, Wagner RL, Weinberger DR, Rieth KG and Wyatt RJ:
Evaluation of CT scans in tardive dyskinesia. American Journal of
Psychiatry 137:247 248, 1980.
26. Jeste DV and Smith GP: Unilateral mesolimbio cortical dopamine
denervation decreases locomotion in the open field and after
amphetamine. Pharmacology, Biochemistry and Behavior 12:453 457,
1980.
27. Bridge TP, Jeste DV, Cutler NR, Phelps BH, Potkin SG, Wise CD,
Wagner RL and Wyatt RJ: Catecholamine enzyme activity and cognitive
function in older psychiatric patients, nursing home residents and
elderly in the community. Gerontologist 20:71, 1980.
28. Jeste DV, Neckers LM, Wagner RL, Wise CD, Staub RA, Rogol A,
Potkin SG, Bridge TP and Wyatt RJ: Lymphocyte monoamine oxidase and
plasma prolactin and growth hormone in tardive dyskinesia. Journal
of Clinical Psychiatry 42:75 77, 1981.
29. Jeste DV and Wyatt RJ: Changing epidemiology of tardive
dyskinesia An overview. American Journal of Psychiatry 138:297 309,
1981.
30. Bridge TP, Jeste DV, Wise CD Potkin SG, Phelps BH and Wyatt RJ:
Platelet monoamine oxidase in aged general population and elderly
chronic schizophrenics. Psychopharmacology Bulletin 17:103 104,
1981.
31. Wyatt RJ, Potkin SG, Kleinman JE, Weinberger DR, Luchins, DJ and
Jeste DV: The schizophrenic syndrome: Examples of biological tools
for subclassification. Journal of Nervous and Mental Disease 169:100
112, 1981.
32. Jeste DV, DeLisi LE, Zalcman S, Wise CD, Phelps BH, Rosenblatt
JE, Potkin SG, Bridge TP and Wyatt RJ: A biochemical study of
tardive dyskinesia in young male patients. Psychiatry Research 4:327
331, 1981.
33. Jeste DV, Doongaji DR, Panjwani D, Dataa M, Potkin SG, Karoum F,
Thatte S, Sheth AS, Apte JS and Wyatt RJ: Cross cultural study of a
biochemical abnormality in paranoid schizophrenia. Psychiatry
Research 5:341 352, 1981.
34. Wyatt RJ, Karoum F, Stoff DM, Kleinman JE, Gillin JC, Jeste DV
and Potkin SG: Monoamine oxidase phenylethylamine, norepinephrine
and schizophrenia. Clinical Genetics 19:437 442, 1981.
35. Jeste DV and Wyatt RJ: Dogma disputed: Is tardive dyskinesia due
to postsynaptic dopamine receptor supersensitivity? Journal of
Clinical Psychiatry 42:455 457, 1981.
36. Donnelly EF, Jeste DV and Wyatt RJ: Tardive dyskinesia and
perceptual dysfunction. Perceptual and Motor Skills 53:689 690,
1981.
37. Jeste DV, Kleinman JE, Potkin SG, Luchins DJ and Weinberger DR:
Ex uno multi: Subtyping the schizophrenia syndrome. (Recipient of
the A.E. Bennett Research Award for 1981) Biological Psychiatry
17:199 222, 1982.
38. Cutler NR, Jeste DV, Karoum F and Wyatt RJ: Low dose apomorphine
reduces plasma homovanillic acid concentrations in medicated
schizophrenic patients. Life Sciences 30:753 756, 1982.
39. Linnoila M, Rosenblatt JE, Jeste DV, Skinner T, Potter WZ and
Wyatt RJ: Disparate serum thioridazine concentrations: HPLC vs
radioreceptor assay. Acta Pharmacologica et Toxicologica 50:25 29,
1982.
40. Jeste DV and Wyatt RJ: Therapeutic strategies against tardive
dyskinesia Two decades of experience. Archives of General Psychiatry
39:803 816, 1982.
41. Doongaji DR, Sheth AS, Desai AB, Apte JS, Thatte S, Vahora SA,
Parikh MD and Jeste DV: Use of metoclopramide in the differential
diagnosis of drug induced involuntary movements. Journal of
Postgraduate Medicine 28:101 106, 1982.
42. Wagner RL, Jeste DV, Phelps BH and Wyatt RJ: Enzyme studies of
tardive dyskinesia. I. One year biochemical follow up. Journal of
Clinical Psychopharmacology 2:312 314, 1982.
43. DeLisi LE, Jeste DV, Phelps BH and Wyatt RJ: Enzyme studies in
tardive dyskinesia. II. Familial aspects. Journal of Clinical
Psychopharmacology 2:315 317, 1982.
44. Jeste DV, Linnoila M, Forids CM, Phelps BH, Wagner RL and Wyatt
RJ: Enzyme studies in tardive dyskinesia. III. Noradrenergic
hyperactivity in a subgroup of TD patients. Journal of Clinical
Psychopharmacology 2:318 320, 1982.
45. Jeste DV and Wyatt RJ: Guest Editorial: Neuroleptics and tardive
dyskinesia: Quo vadis? Journal of Clinical Psychopharmacology 2:303
304, 1982.
46. Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN,
Desai AB, Vahora A, Thatte S, Vevaina T and Bharadwaj J: Tardive
dyskinesia in India: A prevalence study. Journal of Clinical
Psychopharmacology 2:341 344, 1982.
47. Jeste DV, Linnoila M, Wagner RL and Wyatt RJ: Serum neuroleptic
concentrations and tardive dyskinesia. Psychopharmacology 76:377
380, 1982.
48. Stoff DM, Jeste DV, Moja EA, Stauderman KA and Wyatt RJ:
Interaction of monoamine blocking agents with behavioral effects of
N,N dimethyltryptamine. Psychopharmacology Bulletin 18:173 175,
1982.
49. Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN,
Desai AB, Rathi LG, Gandhi MH, Parikh RM, Thatte S and Bharadwaj J:
Effects of Intravenous metoclopramide in 81 patients with tardive
dyskinesia. Journal of Clinical Psychopharmacology 2:376 379, 1982.
50. Jeste DV, Zalcman S, Weinberger DR, Bigelow LB, Kleinman JE,
Rogol A, Gillin JC and Wyatt RJ: Apomorphine response and subtyping
of schizophrenia. Progress in Neuro-Psychopharmacology and
Biological Psychiatry 7:83 88, 1983.
51. Karson CN, Jeste DV, LeWitt PA and Wyatt RJ: A comparison of two
iatrogenic dyskinesias. American Journal of Psychiatry 140:1504
1506, 1983.
52. Karson CN, Kleinman JE, Berman KF, Phelps BH, Wise CD, DeLisi LE
and Jeste DV: An inverse correlation between spontaneous eye blinks
and platelet monoamine oxidase. British Journal of Psychiatry 142:43
46, 1983.
53. Jeste DV, Cutler NR, Kaufmann CA and Karoum F: Low dose
apomorphine and bromocriptine in neuroleptic induced movement
disorders. Biological Psychiatry 18:1085 1091, 1983.
54. Jeste DV, Stoff DM, Freed WJ, Rawlings R and Wyatt RJ: Use of
recombinant inbred strains of mice: An approach to
psychopharmacogenetics. Psychopharmacology Bulletin 19:619 620,
1983.
55. Stoff DM, Jeste DV, Gillin JC, Moja EA, Cohen L, Stauderman KA
and Wyatt RJ: Behavioral supersensitivity to B phenylethylamine
after chronic administration to haloperidol. Biological Psychiatry
19:101 106, 1984.
56. Jeste DV, Doongaji DR and Linnoila M: Elevated cerebrospinal
fluid norepinephrine in tardive dyskinesia. British Journal of
Psychiatry 144:177 180, 1984.
57. Jeste DV, Barban L, Karson CN, Waldman I, Patterson D, Anderson
C and Wyatt RJ: Psychopathology and dyskinesia. Psychopharmacology
Bulletin 20:41, 1984.
58. Freed WJ, Crump S and Jeste DV: Genetic effects of PCP induced
stimulation in recombinant inbred strains of mice. Pharmacology,
Biochemistry, and Behavior 21:159 162, 1984.
59. Cutler NR, Jeste DV, Kaufmann CA, Karoum F, Schran HF and Wyatt
RJ: Low dose bromocriptine: A study of acute effects in chronic
medicated schizophrenics. Progress in Neuro-Psychopharmacology and
Biological Psychiatry 8:277 283, 1984.
60. Jeste DV, Barban L and Parisi J: Reduced Purkinje cell density
in Huntington's disease. Experimental Neurology 85:78 86, 1984.
61. Jeste DV, Karson CN, Iager A, Bigelow LB and Wyatt RJ:
Association of abnormal involuntary movements and negative symptoms.
Psychopharmacology Bulletin 20:380 381, 1984.
62. Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH and Wyatt RJ:
Schizophrenic outcome in late life: Symptom state and platelet
monoamine oxidase activity. Psychiatry Research 11:91 97, 1984.
63. Jeste DV, Stoff DM, Rawlings R and Wyatt RJ: Pharmacogenetics of
phenylethylamine: Determination of heritability and genetic
transmission of locomotor effects of recombinant inbred strains of
mice. Psychopharmacology 84:537 540, 1984.
64. Jeste DV and Wyatt RJ: Prevention and management of tardive
dyskinesia. Journal of Clinical Psychiatry 46:4(Sec. 2):14 18, 1985.
65. Karson CN, Jeste DV and Bigelow LB: Tardive dyskinesia and
psychopathology in chronic schizophrenic patients. A cross sectional
study. Comprehensive Psychiatry 26:388 391, 1985.
66. Jeste DV, del Carmen R, Lohr J and Wyatt RJ: Did schizophrenia
exist before the eighteenth century? Comprehensive Psychiatry 26:493
503, 1985.
67. Jeste DV: An update on tardive dyskinesia: What we know in 1985.
Currents in Affective Illness 4(9):5-10, 1985.
68. Kaufmann CA, Jeste DV, Linnoila M, Shelton R, Kafka M and Wyatt
RJ: Noradrenergic and neuroradiologic abnormalities in tardive
dyskinesia. Biological Psychiatry 21:799 812, 1986.
69. Iager AC, Kirch DG, Jeste DV and Wyatt RJ: Defect symptoms and
abnormal involuntary movement in schizophrenia. Biological
Psychiatry 21:751 755, 1986.
70. Lohr JB and Jeste DV: Cerebellar pathology in schizophrenia? A
neuronometric study. Biological Psychiatry 21:865 875, 1986.
71. Mani RB, Lohr JB and Jeste DV: Hippocampal pyramidal cells and
aging in the human: A quantitative study of neuronal loss in sectors
CAI CA4. Experimental Neurology, 94:29-40, 1986.
72. David AS, Jeste DV, Folstein MF and Folstein SE: Voluntary
movement dysfunction in Huntington's disease and tardive dyskinesia.
Acta Neurol. Scand., 75:130-139, 1987.
73. Lohr JB, Lohr MA, Hilliard B, Larson L, Vardiman E, Wade L,
Wasli E and Jeste DV: Self perception of tardive dyskinesia and
neuroleptic induced parkinsonism: A study of clinical correlates.
Psychopharmacology Bulletin, 23:211-214, 1987.
74. Glazer WM, Morgenstern H, Jeste DV, Zahner G, Hafez HM and
Benarroche CL: Serum dopamine beta hydroxylase activity and tardive
dyskinesia. Psychoneuroendocrinology 12:289-294, 1987.
75. Jeste DV and Zisook S: Preface to Psychosis and Depression in
the Elderly. Psychiatric Clinics of North America. 11:xiii-xv, 1988.
76. Jeste DV, Harris MJ, Pearlson GD, Rabins P, Lesser I, Miller B,
Coles C and Yassa R: Late-onset schizophrenia: Studying clinical
validity. Psychiatric Clinics of North America 11:1-14, 1988.
77. Dupont R, Cullum CM and Jeste DV: Post-stroke depression and
psychosis. Psychiatric Clinics of North America 11:133-150, 1988.
78. Wragg RE and Jeste DV: Neuroleptics and alternative treatments:
Management of behavioral symptoms and psychosis in Alzheimer's
disease and related conditions. Psychiatric Clinics of North
America. 11:195-214, 1988.
79. Sargenti CJ, Rizos AL and Jeste DV: Psychotropic drug reactions
in the patient with late-onset psychosis and mood disorder: Part I.
Psychiatric Clinics of North America. 11:235-252, 1988.
80. Rizos AL, Sargenti CJ and Jeste DV: Psychotropic drug reactions
in the patient with late-onset depression or psychosis: Part II.
Psychiatric Clinics of North America. 11:253-278, 1988.
81. Harris MJ and Jeste DV: Late onset schizophrenia: An overview.
Schizophrenia Bulletin 14:39-55, 1988.
82. Jeste DV and Jeste SD: Neuroleptic-induced tardive dyskinesia.
Clinical Advances in the Treatment of Psychiatric Disorders 2(3):7
and 10, 1988.
83. Lohr JB and Jeste DV: Locus ceruleus morphology in aging and
schizophrenia. Acta Psychiatrica Scandinavia 77:689-697, 1988.
84. Carpenter WT, Schooler NR, Wise SS, Goldman H, Goldstein MJ,
Hogarty GE, Jeste DV, Kane JM, Klerman GL, Liberman RP, Paul SM,
Robinson DS, Spring B, Stahl SM, and Tamminga CA: A national plan
for treatment, services and environmental factors. Schizophrenia
Bulletin 14:427-437, 1988.
85. Harris MJ, Cullum CM and Jeste DV: Clinical presentation of
late-onset schizophrenia. Journal of Clinical Psychiatry 49:356-360,
1988.
86. Jeste DV, Lohr JB, Clark K and Wyatt RJ: Pharmacological
treatment of tardive dyskinesia in the 1980's. Journal of Clinical
Psychopharmacology 8(#4, Aug 88 supplement):38S-48S, 1988.
87. Yassa R and Jeste DV: Tardive dyskinesia 1988: Thirty-one years
later. Journal of Clinical Psychopharmacology (8)(#4, August 88
supplement):1S, 1988.
88. Shiromani PJ, Armstrong DM, Berkowitz A, Jeste DV and Gillin JD:
Distribution of choline acetyltransferase immunoreactive somata in
the feline brain stem: Implications for REM sleep generation sleep.
Sleep Vol 11, No. 1, pp 1-16, 1988.
89. Lam RW, Jeste SD and Jeste DV: Preventing neuroleptic-induced
tardive dyskinesia in adults and children. L'Encephale 14:251-255,
1988.
90. Caligiuri MP, Harris MJ and Jeste DV: Quantitative analyses of
voluntary orofacial motor control in schizophrenia and tardive
dyskinesia. Biological Psychiatry 24:787-800, 1988.
91. Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R,
Vidoni C, Jeste DV and Wyatt RJ: Vitamin E in the treatment of
tardive dyskinesia: The possible involvement of free radical
mechanisms. Schizophrenia Bulletin 14:291-296, 1988.
92. Jeste DV, Lohr JB and Goodwin FK: Neuroanatomical studies of
major affective disorders: A review and suggestions for further
research. British Journal of Psychiatry 153:444-459, 1988.
93. Jeste DV, Harris MJ and Rockwell E: Is pseudodementia a pseudo
entity? Bulletin of Clinical Neuroscience 53:20-24, 1988.
94. Ko G, Zhang LD, Yan WW, Zhang MD, Buchner D, Xia ZY, Wyatt RJ
and Jeste DV: The Shanghai 800: Tardive dyskinesia prevalence in
China. American Journal of Psychiatry 146:387-389, 1989.
95. Harris MJ and Jeste DV: Evaluation and management of HIV/AIDS
and psychosis. Clinical Advances in the Treatment of Psychiatric
Disorders 3:2:8-9, 1989.
96. Wragg R and Jeste DV: Overview of depression and psychosis in
Alzheimer's disease. American Journal of Psychiatry 146:5:577-587,
1989.
97. Jeste DV and Lohr JB: Hippocampal pathologic findings in
schizophrenia: A morphometric study. Archives of General Psychiatry
46:1019-1024, 1989.
98. Lawson WB, Jeste DV, Kopp V, Wyatt RJ and Hanin I: RBC and
plasma choline in neuroleptic treated schizophrenic patients.
Psychiatry Research 29:45-53, 1989.
99. Sewell D and Jeste DV: Neuroleptic malignant syndrome: A review.
Japanese Journal of Psychopharmacology 9:319-333, 1989.
100. Caligiuri MP, Jeste DV and Harris MJ: Instrumental assessment
of lingual motor instability in tardive dyskinesia.
Neuropsychopharmacology 2:309-312, 1989.
101. Jeste DV, Harris MJ, Grant I and Thal L: Psychopathology in
dementia. Bulletin of Clinical Neuroscience 54:51-58, 1989.
102. Lohr JB, Kuczenski R, Bracha HS, Moir M and Jeste DV: Increased
indices of free radical activity in the cerebrospinal fluid of
patients with tardive dyskinesia. Biological Psychiatry 28:535-539,
1990.
103. Jeste DV, Gierz M and Harris MJ: Pseudodementia: Myths and
reality. Psychiatry Annals 20:71-79, 1990.
104. Jeste DV and Krull AJ: Editorial: Neuroleptics and tardive
dyskinesia: A case of iatrogenesis. Western Journal of Medicine,
153:5:560-561, 1990.
105. Jeste DV, Krull AJ and Kilbourn K: Tardive dyskinesia: Managing
a common neuroleptic side effect. Geriatrics 45:12:49-54, 1990.
106. Gariano RF, Young SJ, Jeste DV, Segal DS and Groves PM: Effects
of long-term administration of haloperidol on electrophysiological
properties of rat mesencephalic neurons. Journal of Pharmacology and
Experimental Therapeutics 225 (1):108-113, 1990.
107. Caligiuri MP, Lohr JB, Bracha HS and Jeste DV: Clinical and
instrumental assessment of neuroleptic-induced parkinsonism in
patients with tardive dyskinesia. Biological Psychiatry 29: 139-148,
1991.
108. Krull AJ, Press G, Dupont R, Harris MJ and Jeste DV: Brain
imaging in late-onset schizophrenia and related psychoses.
International Journal of Geriatric Psychiatry, 6:651-658, 1991.
109. Caligiuri MP, Lohr JB and Jeste DV: Instrumental evidence that
age increases motor instability in neuroleptic-treated patients.
Journal of Gerontology 46:197-200, 1991.
110. Harris MJ, Jeste DV, Gleghorn A and Sewell D: New onset
psychosis in HIV-infected patients. Journal of Clinical Psychiatry
52:369-376, 1991.
111. Jeste DV and Krull AJ: Behavioral problems associated with
dementia: Diagnosis and treatment. Geriatrics 46:28-34, 1991.
112. Jeste DV and Caligiuri MP: Biological research in geriatric
psychiatry. Biological Psychiatry 30:855-856, 1991.
113. Jeste DV, Wragg RE, Salmon DP, Harris MJ and Thal LJ: Cognitive
deficits of patients with Alzheimer disease with and without
delusions. American Journal of Psychiatry 149:184-189, 1992.
114. Harris MJ, Jeste DV, Krull A, Montague J and Heaton RK: Deficit
syndrome in older schizophrenic patients. Psychiatry Research.
29:285-292, 1992.
115. Jeste DV, Lohr JB and Manley M: Study of neuropathologic
changes in the striatum following four, eight and twelve months of
treatment with fluphenazine in rats. Psychopharmacology.
106:154-160, 1992.
116. Lesser IM, Jeste DV, Boone KB, Harris MJ, Miller B, Heaton RK
and Hill-Gutierrez E: Late-onset psychotic disorder, not otherwise
specified (NOS): Clinical, neuropsychological and neuroimaging
findings. Biological Psychiatry. 31:419-423, 1992.
117. Harris MJ, Panton D, Caligiuri MP, Krull AJ, Tran-Johnson TK
and Jeste DV: High incidence of tardive dyskinesia in older
outpatients on low doses of neuroleptics. Psychopharmacology
Bulletin, 28: 87-92, 1992.
118. Lauriello J and Jeste DV: Neuroleptic treatment of
schizophrenia. Comprehensive Therapy, 18: 30-35, 1992.
119. Sewell DD and Jeste DV: Distinguishing neuroleptic malignant
syndrome (NMS) from NMS-like acute medical illnesses: a study of 34
cases. Journal of Neuropsychiatry and Clinical Neurosciences, 4:
265-269, 1992.
120. Yassa R and Jeste DV: Gender differences in tardive dyskinesia:
A critical review of the literature. Schizophrenia Bulletin, 18(4):
701-715, 1992.
121. Sewell DD and Jeste DV: Metoclopramide-associated tardive
dyskinesia: An analysis of 67 cases. Archives of Family Medicine, 1:
271-278, 1992.
122. Sewell DD, Yoshinobu BH, Caligiuri MP and Jeste DV:
Metoclopramide-associated tardive dyskinesia in hemodialysis
patients with diabetes mellitus: Two case reports. General Hospital
Psychiatry, 14: 416-419, 1992.
123. Jeste DV, Fitten LJ, Clemons B, O'Neal S and Harris MJ: A
survey of geriatric psychiatrists in the U.S. regarding research.
International Journal of Geriatric Psychiatry, 8: 13-18, 1993.
124. Lacro JP, Harris MJ and Jeste DV: Late-life psychosis.
International Journal of Geriatric Psychiatry, 8: 49-57, 1993.
125. Gierz M and Jeste DV: Physical comorbidity in elderly veterans
affairs patients with schizophrenia and depression. American Journal
of Geriatric Psychiatry, 1: 165-170, 1993.
126. Jeste DV: Late-onset schizophrenia (Editorial): International
Journal of Geriatric Psychiatry, 8: 283-285, 1993.
127. Jeste DV and Caligiuri MP: Tardive dyskinesia. Schizophrenia
Bulletin 19:303-315, 1993.
128. Caligiuri MP, Lohr JB and Jeste DV: Parkinsonism in
neuroleptic-naive schizophrenic patients. American Journal of
Psychiatry 150:1343-1348, 1993.
129. Jeste DV: Late-life schizophrenia: Editor's Introduction.
Schizophrenia Bulletin 19(4):687-689, 1993.
130. Prager S and Jeste DV: Sensory impairment in late-life
schizophrenia. Schizophrenia Bulletin 19(4):755-772, 1993.
131. Jeste DV, Lacro JP, Gilbert PL, Kline J and Kline N: Treatment
of late-life schizophrenia with neuroleptics. Schizophrenia Bulletin
19(4):817-830, 1993.
132. Copeland JRM and Jeste, DV: Geriatric psychiatry: Editorial
overview. Current Opinion in Psychiatry 6:529-530, 1993.
133. Rockwell E, Krull AJ, Dimsdale J and Jeste DV: Late-onset
psychosis with somatic delusions. Psychosomatics 35:66-72, 1994.
134. Lacro JP, Sewell DD, Warren K, Woody S, Harris MJ and Jeste DV:
Improving documentation of consent for neuroleptic therapy. Hospital
and Community Psychiatry 45(2):176-178, 1994.
135. Sewell DD, Jeste DV, Atkinson JH, Heaton RK, Hesselink JR,
Wiley C, Thal L, Chandler JL, Grant I and the HNRC Group:
HIV-associated psychosis: A study of 20 cases. American Journal of
Psychiatry 151(2):237-242, 1994.
136. Rockwell E, Jackson E, Vilke G and Jeste DV: A study of
delusions in a large cohort of Alzheimer's disease patients.
American Journal of Geriatric Psychiatry 2(2):157-164, 1994.
137. Paulsen JS, Heaton R and Jeste DV: Neuropsychological
impairment in tardive dyskinesia. Neuropsychology 8(2):227-241,
1994.
138. Heaton R, Paulsen J, McAdams LA, Kuck J, Zisook S, Braff D,
Harris MJ and Jeste DV: Neuropsychological deficits in
schizophrenics: Relationship to age, chronicity and dementia.
Archives of General Psychiatry 51:469-476, 1994.
139. Sewell DD, Jeste DV, McAdams L, Bailey A, Harris MJ, Atkinson
JH, Chandler JL, McCutchan JA, Grant I and the HNRC Group:
Neuroleptic Treatment of HIV-Associated Psychosis.
Neuropsychopharmacology 10:223-229, 1994.
140. Jeste DV: Geriatric psychiatry in the next millennium
(Editorial comment). Current Opinion in Psychiatry 7:4:335-336,
1994.
141. Lacro JP and Jeste DV: Physical comorbidity and polypharmacy in
older psychiatric patients. Biological Psychiatry, 36:146-152, 1994.
142. Lacro JP, Gilbert PL, Paulsen JS, Fell R, Bailey A, Juels C,
Caligiuri M, McAdams LA, Harris MJ and Jeste DV: Early course of
new-onset tardive dyskinesia in older patients. Psychopharmacology
Bulletin 30(2):187-191, 1994.
143. Jeste DV; Gottlieb GL, Katz, IR: Fundamentals-oriented clinical
research: The need for reconsideration. Guest Editorial. American
Journal of Geriatric Psychiatry 2(4):282-284, 1994.
144. Sewell DD, Kodsi AB, Caligiuri MP and Jeste DV: Metoclopramide
and Tardive Dyskinesia. Biological Psychiatry 36:630-632, 1994.
145. Cullum CM, Heaton RK, Harris MJ and Jeste DV: Neurobehavioral
and neurodiagnostic aspects of late-onset psychosis. Archives of
Clinical Neuropsychology 9(5):371-382, 1994.
146. Dupont RM, Lehr P, Lamoureaux G, Halpern S, Harris MJ and Jeste
DV: Preliminary Report: Cerebral blood flow abnormalities in older
schizophrenic patients. Psychiatry Research: Neuroimaging,
55:121-130, 1994.
147. Granholm E and Jeste DV: Cognitive impairment in schizophrenia.
Psychiatric Annals 24:484-490, 1994.
148. Gierz M, Sewell DD, Kramer R, Gillin JC and Jeste DV: Psychotic
versus nonpsychotic depression in older patients. American Journal
of Geriatric Psychiatry, 3(1): 75-80, 1995.
149. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D,
Kuck J, Zisook S and Jeste DV: The nature of learning and memory
impairments in schizophrenia. Journal of International
Neuropsychology Society 1:88-99, 1995.
150. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ and Jeste DV:
Quantitative magnetic resonance imaging of the brain in late-life
schizophrenia. American Journal of Psychiatry 152:447-449, 1995.
151. Gilbert PL, Harris MJ, McAdams LA and Jeste DV: Neuroleptic
withdrawal in schizophrenic patients: A review of the literature.
Archives of General Psychiatry, 52:173-188, 1995.
152. Jeste DV, Gilbert P, McAdams LA and Harris MJ: Considering
neuroleptic maintenance and taper on a continuum: Need for
individual, rather than dogmatic, approach. Archives of General
Psychiatry, 52:209-212, 1995.
153. Jeste DV, Harris MJ, Krull A, Kuck J, McAdams LA and Heaton, R:
Clinical and neuropsychological characteristics of patients with
late-onset schizophrenia. American Journal of Psychiatry
152(5):722-730, 1995.
154. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris
MJ, Bailey A, Fell RL and McAdams LA: Risk of tardive dyskinesia in
older patients: A prospective longitudinal study of 266 outpatients.
Archives of General Psychiatry, 52:756-765, 1995.
155. Hayashi T, Yamawaki S, Nishikawa T, Jeste DV: Usage and side
effects of neuroleptics in elderly Japanese patients. American
Journal of Geriatric Psychiatry, 3:308-316, 1995.
156. Christensen K, Haroun A, Schneiderman LJ and Jeste DV:
Decision-making capacity for informed consent in the older
population. Bulletin of the American Academy of Psychiatry and the
Law, 23:353-365, 1995.
157. Zisook S, Byrd D, Kuck J and Jeste DV: Command hallucinations
in outpatients with schizophrenia. Journal of Clinical Psychiatry,
56(10):462-465, 1995.
158. Koran LM, Holman S, Hertzman M, Meyers BS, Halaris AE,
Tollefson GD, Downs JM, Folks DG, Jeste DV, Lazarus LW and Satlin A:
Predicting response to fluoxetine in geriatric patients with major
depression. Journal of Clinical Psychopharmacology, 15(6):421-427,
1995.
159. Naimark D, Jackson E, Rockwell E and Jeste DV: Psychotic
symptoms in Parkinson's disease patients with dementia. Journal of
the American Geriatrics Society 44(3):296-299, 1996.
160. Jeste DV, Heaton SC, Paulsen JS, Ercoli L, Harris MJ and Heaton
RK: Clinical and neuropsychological comparison of psychotic
depression with nonpsychotic depression and schizophrenia. American
Journal of Psychiatry 153(4):490-496, 1996.
161. Paulsen JS, Caligiuri MP, Palmer B, McAdams LA and Jeste DV:
Risk factors for orofacial and limbtruncal tardive dyskinesia in
older patients: A prospective longitudinal study. Psychopharmacology
123:307-314, 1996.
162. McAdams LA, Harris MJ, Bailey A, Fell R and Jeste DV:
Validating specific psychopathology scales in older outpatients with
schizophrenia. The Journal of Nervous and Mental Disease
184(4):246-251, 1996.
163. Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris, MJ:
Management of late-life psychosis. Journal of Clinical Psychiatry
57(Supp. 3):39-45, 1996.
164. Cuffel BJ, Jeste DV, Patterson TL, Halpain M, Pratt C:
Treatment costs and use of community mental health services for
schizophrenia by age-cohorts. American Journal of Psychiatry 153(7):
870-876, 1996.
165. Lacro JP, Eastham JH, Jeste DV and Lohr JB: Newer
antipsychotics and antidepressants for elderly people. Current
Opinion in Psychiatry 9(4):290-293, 1996.
166. Jeste DV: Growing disparity between need and reality: Research
in geriatric psychiatry (Editorial). Current Opinion in Psychiatry
9(4):279-280, 1996.
167. Granholm E, Asarnow RF, Verney SP, Nelson P and Jeste DV: Span
of apprehension deficits in older outpatients with schizophrenia.
Schizophrenia Research 20:51-56, 1996.
168. Lacro JP, Kuczenski R, Roznoski M, Warren KA, Harris MJ and
Jeste DV: Serum haloperidol levels in older psychotic patients.
American Journal of Geriatric Psychiatry 4:229-236, 1996.
169. Jeste DV, Lindamer LA, Evans J and Lacro JP: Relationship of
ethnicity and gender to schizophrenia and pharmacology of
neuroleptics. Psychopharmacology Bulletin 32(2):243-251, 1996.
170. Jeste DV, Gladsjo JA, Lindamer LA and Lacro JP: Medical
comorbidity in schizophrenia. Schizophrenia Bulletin 22(3):413-430,
1996.
171. Rapaport MH, Bazzetta J, McAdams LA, Patterson T and Jeste DV:
Validation of the scale of functioning in older outpatients with
schizophrenia. American Journal of Geriatric Psychiatry
4(3):218-228, 1996.
172. Perry W, Potterat E, Auslander L, Kaplan E and Jeste DV: A
neuropsychological approach to the Rorschach in patients with
dementia of the Alzheimer type. Assessment (special issue on
Neuropsychology of Personality). Assessment 3(3):351-363, 1996.
173. Evans JD, Paulsen JS, Harris MJ, Heaton RK and Jeste DV: A
Clinical and neuropsychological comparison of delusional disorder
and schizophrenia. Journal of Neuropsychiatry and Clinical
Neurosciences. 8(3):281-286, 1996.
174. Eastham JH, Lacro JP and Jeste DV: Ethnicity and movement
disorders. The Mount Sinai Journal of Medicine 63(5&6):314-319,
1996.
175. Patterson TL, Kaplan RM, Grant I, Semple SJ, Moscona S, Koch
WL, Harris MJ and Jeste DV: Quality of well-being in late-life
psychosis. Psychiatry Research 63:169-181, 1996.
176. Patterson TL, Semple SJ, Shaw WS, Grant I and Jeste DV:
Researching the caregiver: Family members who care for older
psychotic patients. Psychiatric Annals 26(12) 772-784, 1996.
177. Palmer BW and Jeste DV: Neurodevelopmental theories of
schizophrenia: Application to late-onset schizophrenia. Indian
Journal of Psychiatry 38(1):13-22, 1996.
178. Paulsen JS, Romero, R., Chan A, Davis AV, Heaton RK and Jeste
DV: Impairment of the semantic network in schizophrenia. Psychiatry
Research 63:109-121, 1996.
179. Eastham JH and Jeste DV: Differentiating behavioral
disturbances of dementia from drug side effects. International
Psychogeriatrics 8(3):429-434, 1996.
180. Jeste DV, Rockwell E, Harris MJ, Eastham J and Lacro J: New
research on psychotic symptoms in schizophrenia. Clinical Geriatrics
Supplement A:10-15, January 1997.
181. Jeste DV and Kelsoe JR: Schizophrenia, tardive dyskinesia and a
D3 receptor gene variant: A new twist on dyskenesias? Molecular
Psychiatry 2:86-88, 1997.
182. Patterson TL, Shaw W, Semple SJ, Moscona S, Harris MJ, Kaplan
RM, Grant I and Jeste DV: Health-related quality of life in older
patients with schizophrenia and other psychoses: Relationships among
psychosocial and psychiatric factors. International Journal of
Geriatric Psychiatry 12(4):452-461, 1997.
183. Lopez W and Jeste DV: Movement disorders and substance abuse.
Psychiatric Services 48(5):634-636, 1997.
184. Klapow JC, Evans J, Patterson TL, Heaton RK, Koch WL and Jeste
DV: Direct assessment of functional status in older patients with
schizophrenia. American Journal of Psychiatry 154:1022-1024, 1997.
185. Olichney JM, Iragui VJ, Kutas M, Nowacki R and Jeste DV: N400
Abnormalities in late life schizophrenia and related psychoses.
Biological Psychiatry 42:13-23, 1997.
186. Semple SJ, Patterson TL, Shaw WS, Grant I, Moscona S, Koch W,
Jeste DV and the CRC on Late Life Psychosis Research Group: The
social networks of older schizophrenia patients. International
Psychogeriatrics, 9(1):81-94, 1997.
187. Halpain M, Jeste DV, Katz IR and Lebowitz BD: The first summer
research institute in geriatric psychiatry. American Journal of
Geriatric Psychiatry, 5(3):238-246, 1997.
188. Jeste DV, Klausner M, Brecher M, Clyde C, Jones R and the ARCS
Study Group: A clinical evaluation of risperidone in the treatment
of schizophrenia: A 10-week, open-label, multicenter trial.
Psychopharmacology 131(3):239-247, 1997.
189. Lindamer LA, Lohr JB, Harris MJ and Jeste DV: Gender, estrogen,
and schizophrenia. Psychopharmacology Bulletin 33(2):221-228, 1997.
190. Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ,
Zisook S and Jeste DV: Is it possible to be schizophrenic yet
neuropsychologically normal? Neuropsychology 11(3):437-446, 1997.
191. Lacro JP and Jeste DV: Geriatric psychosis. Psychiatric
Quarterly 68(3):247-260, 1997.
192. Granholm E, Morris SK, Sarkin AJ, Asarnow RF and Jeste DV:
Pupillary responses index overload of working memory resources in
schizophrenia. Journal of Abnormal Psychology 106(3):458-467, 1997.
193. Caligiuri MP, Lacro JP, Rockwell E, McAdams LA and Jeste DV:
Incidence and risk factors for severe tardive dyskinesia in older
patients. British Journal of Psychiatry 171:148-153, 1997.
194. Jeste DV: Psychiatry of old age is coming of age (Guest
editorial). American Journal of Psychiatry 154(10):1356-1358, 1997.
195. Symonds LL, Olichney JM, Jernigan TL, Corey-Bloom J, Healy JF
and Jeste DV: Lack of clinically significant gross structural
abnormalities in MRIs of older patients with schizophrenia and
related psychoses. The Journal of Neuropsychiatry and Clinical
Neurosciences 9(2):251-258, 1997.
196. Eastham JH and Jeste DV: Treatment of schizophrenia and
delusional disorder in the elderly. European Archives of Psychiatry
and Clinical Neuroscience, 247(4):209-218, 1997.
197. Jeste DV, Symonds LL, Harris MJ, Paulsen JS, Palmer BW and
Heaton RK: Non-dementia non-praecox dementia praecox?: Late-onset
schizophrenia. American Journal of Geriatric Psychiatry
5(4):302-317, 1997.
198. Jeste DV: Schizophrenia, antipsychotics and aging (Guest
Editorial). Schizophrenia Research 27: 103-104, 1997.
199. Morris SK, Granholm E, Sarkin AJ and Jeste DV: Effects of
schizophrenia and aging on pupillographic measures of working
memory. Schizophrenia Research 27:119-128, 1997.
200. Kindermann SS, Karimi A, Symonds L, Brown GG and Jeste DV:
Review of functional magnetic resonance imaging (fMRI) in
schizophrenia. Schizophrenia Research 27:143-156, 1997.
201. Turner EE, Fedtsova N and Jeste DV: The cellular and molecular
neuropathology of schizophrenia: New directions from developmental
neurobiology. Schizophrenia Research 27:169-180, 1997.
202. Patterson TL, Semple SJ, Shaw WS, Halpain M, Moscona S, Grant I
and Jeste DV: Self-reported social functioning among older patients
with schizophrenia, Schizophrenia Research 27:199-210, 1997.
203. McAdams LA, Harris MJ, Heaton SC, Bailey A, Fell R and Jeste
DV: Validity of specific subscales of the positive and negative
symptom scales in older schizophrenia outpatients. Schizophrenia
Research 27:219-226, 1997.
204. Jeste DV and Harris MJ: Depression and dementia. Medical
Advances - Health in Mind and Body 2(1):5, 1997.
205. Palmer BW, Jeste DV and Sheikh JI: Anxiety disorders in the
elderly: DSM-IV and other barriers to diagnosis and treatment.
Journal of Affective Disorders, 46:183-190, 1997.
206. Ellis RJ, Jan K, Kawas C, Koller WC, Lyons KE, Jeste DV, Hansen
LA and Thal LJ: Diagnostic validity of the dementia questionnaire
for Alzheimer’s disease. Archives of Neurology 55:360-365, 1998.
207. Eastham JH, Jeste DV and Young RC: Assessment and treatment of
bipolar disorder in the elderly. Drugs and Aging 12(3):205-224,1998.
208. Sciolla A and Jeste DV: Use of antipsychotics in the elderly.
International Journal of Psychiatry in Clinical Practice 2: S27-S34,
1998.
209. Caligiuri MP, Rockwell E and Jeste DV: Extrapyramidal side
effects in patients with Alzheimer’s disease treated with low-dose
neuroleptic medication. American Journal of Geriatric Psychiatry 6
(1): 75-82, 1998.
210. Jeste DV and Davidson M: The pharmacotherapy of psychotic
symptoms in the elderly. Clinician 16(1): 22-32, 1998.
211. Jeste DV and Palmer BW: Secondary psychosis: An overview.
Seminars in Clinical Neuropsychiatry 3(1): 2-3, 1998.
212. Peyser CE, Naimark D, Zuniga R and Jeste DV: Psychoses in
Parkinson’s disease. Seminars in Clinical Neuropsychiatry 3(1):
41-50, 1998.
213. Jeste DV, Lohr JB, Eastham JH, Rockwell E and Caligiuri MP:
Adverse effects of long-term use of neuroleptics: Human and animal
studies. Journal of Psychiatry Research 32:201-214, 1998.
214. Olichney JM, Iragui VJ, Kutas M, Nowacki R, Morris S and Jeste
DV: Relationship between auditory P300 amplitude and age of onset of
schizophrenia in older patients. Psychiatry Research 79:241-254,
1998.
215. Jeste DV, McAdams LA, Palmer BW, Braff D, Jernigan TL, Paulsen
JS, Stout J, Symonds LL, Bailey A and Heaton RK: Relationship of
neuropsychological and MRI measures to age of onset of
schizophrenia. Acta Psychiatrica Scandinavica 98: 156-164, 1998.
216. Halpain MC and Jeste DV: Schizophrenia in the elderly. The
Journal for the California Alliance for the Mentally Ill: 71-73,
1998.
217. Patterson TL, Klapow JC, Eastham JH, Heaton RK, Evans JD, Koch
WL and Jeste DV: Correlates of functional status in older patients
with schizophrenia. Psychiatry Research 80:41-52, 1998.
218. Jeste DV: Late paraphrenia is not late-onset schizophrenia but
a different illness: Column Con. Journal of Psychotic Disorders
2(4): 3,15, 1998.
219. Jeste DV: Pro/Con: Discussion: Column Con: Rebuttal to the
article by Dr. Howard. Journal of Psychotic Disorders 2(4): 16,
1998.
220. Jeste DV, Rockwell E, Harris MJ, Lohr JB and Lacro J:
Conventional versus newer antipsychotics in elderly patients.
American Journal of Geriatric Psychiatry 7 (1):70-76, 1999.
221. Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ and
Caligiuri MP: Incidence of tardive dyskinesia in early stages of
low-dose treatment with typical neuroleptics in older patients.
American Journal of Psychiatry 156: 309-311, 1999.
222. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M
for the Risperidone Study Group: Comparison of risperidone and
placebo for psychosis and behavioral disturbances associated with
dementia: A randomized, double-blind trial. Journal of Clinical
Psychiatry 60: 107-115, 1999.
223. Lindamer LA, Lohr JB, Harris MJ, McAdams LA and Jeste DV:
Gender-related clinical differences in older patients with
schizophrenia. Journal of Clinical Psychiatry 60: 61-67, 1999.
224. Palmer BW, Heaton RK and Jeste DV: Extrapyramidal symptoms and
neuropsychological deficits in schizophrenia. Biological Psychiatry
45: 791-794, 1999.
225. Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ and Jeste DV: Use
of oral reading to estimate premorbid intellectual and
neuropsychological functioning. Journal of the International
Neuropsychological Society 5: 247-254, 1999.
226. McClure FS, Gladsjo JA and Jeste DV: Late-onset psychosis:
Clinical, research, and ethical considerations. American Journal of
Psychiatry 156:6; 935-940, 1999.
227. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ and
Caligiuri MP: Lower incidence of tardive dyskinesia with risperidone
compared with haloperidol in older patients. Journal of the American
Geriatrics Society 47: 716-719, 1999.
228. Ancoli-Israel S, Martin J, Jones DW, Caligiuri M, Patterson T,
Harris MJ and Jeste DV: Sleep-disordered breathing and periodic limb
movements in sleep in older patients with schizophrenia. Biological
Psychiatry 45: 1426-1432, 1999.
229. Patterson TL, Kaplan RM and Jeste DV: Measuring the effect of
treatment on quality of life in patients with schizophrenia: Focus
on utility based measures. CNS Drugs. 12(1), 49 64, 1999.
230. Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ,
Gottlieb GL, Halpain MC, Palmer BW, Patterson TL, Reynolds CF and
Lebowitz BD: Consensus statement on the upcoming crisis in geriatric
mental health: Research agenda for the next two decades. Archives of
General Psychiatry, 56:848-853, 1999.
231. Jeste DV and Munoz RA: Introduction: Preparing for the future.
Psychiatric Services 56:1157, 1999.
232. Cummings JL and Jeste DV: Alzheimer’s disease and its
management in the year 2010. Psychiatric Services 50:1173-1177,
1999.
233. Palmer BW, Heaton SC and Jeste DV: Older patients with
schizophrenia: Challenges in the coming decades. Psychiatric
Services 50:1178-1183, 1999.
234. Patterson TL and Jeste DV: The potential impact of the
baby-boom generation on substance abuse among elderly persons.
Psychiatric Services 50:1184-1187, 1999.
235. Halpain MC, Harris MJ, McClure FS and Jeste DV: Training in
geriatric mental health: Needs and strategies. Psychiatric Services
50:1205-1208, 1999.
236. Evans JD, Negron AE, Palmer BW, Paulsen JS, Heaton RK and Jeste
DV: Cognitive deficits and psychopathology in institutionalized
versus community-dwelling elderly schizophrenia patients. Journal of
Geriatric Psychiatry and Neurology, 12: 11-15, 1999.
237. Magulac M, Landsverk J, Golshan S and Jeste DV: Abnormal
involuntary movements in neuroleptic-naive children and adolescents.
Canadian Journal of Psychiatry. 44: 368-373, 1999.
238. Caligiuri MP, Lacro JP and Jeste DV: Incidence and predictors
of drug-induced parkinsonism in older psychiatric patients treated
with very low doses of neuroleptics. Journal of Clinical
Psychopharmacology, 19:322 328, 1999.
239. Zisook S, McAdams LA, Kuck J, Harris MJ, Bailey A, Patterson
TL, Judd LL and Jeste DV: Depressive symptoms in schizophrenia.
American Journal of Psychiatry, 156(11): 1736-1743, 1999.
240. Jeste DV, Palmer BW and Harris MJ: Neuroleptic discontinuation
in clinical and research settings: Scientific issues and ethical
dilemmas. Biological Psychiatry, 46: 1050-1059, 1999.
241. Jeste DV: Introduction: Newer drugs for older patients. Journal
of Clinical Psychiatry, 60(supp 3): 3-4, 1999.
242. Lindamer LA and Jeste DV: Estrogen and Psychosis: Is there an
association? International Psychiatry Today: 8(2);5 7, 1999.
243. Grundman M, Ellis R, Klauber M, Jeste D, Grant I and Thal LJ:
Importance of both clinical and marital status on survival in
Alzheimer’s disease. Research and Practice in Alzheimer’s Disease
2:304-316, 1999.
244. Evans JD, Heaton RK, Paulsen JS, McAdams LA, Heaton SC and
Jeste DV: Schizoaffective disorder: A form of schizophrenia or
affective disorder? Journal of Clinical Psychiatry, 60:
874-882,1999.
245. Semple SJ, Patterson TL, Shaw WS, Grant I, Moscona S and Jeste
DV: Self-perceived interpersonal competence in older schizophrenia
patients: The role of patient characteristics and psychosocial
factors. Acta Psychiatrica Scandinavica 100: 126-135, 1999.
246. Granholm E, Morris S, Asarnow RF, Chock D and Jeste DV:
Accelerated age-related decline in processing resources in
schizophrenia: Evidence from pupillary responses recorded during the
span of apprehension task. Journal of the International
Neuropsychological Society, 6: 30-43, 2000.
247. Jeste DV and Finkel SI: Psychosis of Alzheimer’s disease and
related dementias: Diagnostic criteria for a distinct syndrome.
American Journal of Geriatric Psychiatry 8: 29-34, 2000.
248. Howard R, Rabins P, Seeman MV, Jeste DV and the International
Late-Onset Schizophrenia Group: Late-onset schizophrenia and
very-late-onset schizophrenia-like psychosis: An international
consensus. American Journal of Psychiatry, 157:172-178, 2000.
249. Jeste DV, Harless KA and Palmer BW: Chronic late-onset
schizophrenia-like psychosis that remitted: Revisiting Newton's
psychosis? American Journal of Psychiatry, 157(3): 444-449, 2000.
250. Jeste DV: Tardive dyskinesia in older patients. Journal of
Clinical Psychiatry, 61 (suppl 4): 27-32, 2000.
251. Shaw WS, Patterson TL, Semple SJ, Halpain MC, Koch WL, Harris
MJ, Grant I and Jeste DV: Use of community support services by
middle-aged and older patients with psychotic disorders. Psychiatric
Services, 51 (4):506-512, 2000.
252. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C,
Galasko D, Hofstetter CR, Thomas R, Grant I and Jeste DV: Incidence
of and risk factors for hallucinations and delusions in patients
with probable AD. Neurology, 54: 1965-1971, 2000.
253. Jeste DV, Okamoto A, Napolitano J, Kane JM and Martinez RA: Low
incidence of persistent tardive dyskinesia in elderly patients with
dementia treated with risperidone. American Journal of Psychiatry
157 (7):1150-1155, 2000.
254. Eyler Zorrilla LT, Heaton RK, McAdams LA, Zisook S, Harris JM
and Jeste DV: Cross sectional study of older outpatients with
schizophrenia and healthy comparison subjects: No differences in age
related cognitive decline. American Journal of Psychiatry 157 (8):
1324-1326, 2000.
255. Jeste DV and Lacro JP: Characteristics of an ideal drug for
behavioral and psychological symptoms of dementia. International
Psychogeriatrics 12 (1): 213-215, 2000.
256. Jeste DV and Glick ID: Editors’ Introduction: Intervention
research in psychosis: Past, present, and future. Schizophrenia
Bulletin, 26(3): 527-531, 2000.
257. Rockwell E, Choure J, Galasko D, Olichney J and Jeste DV:
Psychopathology at initial diagnosis in dementia with Lewy bodies
versus Alzheimer's Disease: Comparison of matched groups with
autopsy-confirmed diagnoses. International Journal of Geriatric
Psychiatry 15: 819-823, 2000.
258. Samuel W, Caligiuri MP, Galasko D, Lacro JP, Marini M, McClure
FS, Warren K and Jeste DV: Better cognitive and psychopathologic
response to donepezil in patients prospectively diagnosed as
dementia with Lewy bodies: A preliminary study. International
Journal of Geriatric Psychiatry 15: 794-802, 2000.
259. Ashley RV, Rockwell E, Gladsjo JA and Jeste DV: The
reappearance of depression in an elderly man: What is lurking
behind? American Journal of Psychiatry 157(12): 1943-1947, 2000.
260. Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I and
Jeste DV: Neurobehaviors and psychotic symptoms in Alzheimer's
disease. Journal of International Neuropsychological Society 6:
815-820, 2000.
261. Caligiuri MP, Jeste DV and Lacro JP: Antipsychotic-induced
movement disorders in the elderly: Epidemiology and treatment
recommendations. Drugs and Aging 17(5): 363-384, 2000.
262. Jeste DV: Geriatric psychiatry may be the mainstream psychiatry
of the future. American Journal of Psychiatry 157(12): 1912-1914,
2000.
263. McQuaid JR, Granholm E, Patterson TL, McClure FS, Roepke S,
Pedrelli P and Jeste DV: Development of an integrated cognitive
behavioral, social skills training intervention for older patients
with schizophrenia. The Journal of Psychotherapy Practice and
Research. 9: 149-156, 2000.
264. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD and Jeste
DV: Stability and course of neuropsychological deficits in
schizophrenia. Archives of General Psychiatry 58:24-32, 2001.
265. Martin J, Jeste DV, Caligiuri MP, Patterson T, Heaton R and
Ancoli-Israel S: Actigraphic estimates of circadian rhythms and
sleep/wake in older schizophrenia. Schizophrenia Research 47:77-86,
2001.
266. Palmer BW, McClure FS and Jeste DV: Schizophrenia in late-life:
Findings challenge traditional concepts. Harvard Review of
Psychiatry 9:51-58, 2001.
267. Halpain MC, Jeste DV, Katz IR, Reynolds CF, Small GW, Borson S
and Lebowitz BD: Summer Research Institute: Enhancing research
career development in geriatric psychiatry. Academic Psychiatry
25:48-56, 2001.
268. Lindamer LA, Buse DC, Lohr JB and Jeste DV: HRT in
Postmenopausal women with schizophrenia: Positive effect on negative
symptoms? Biological Psychiatry 49:47-51, 2001.
269. Dunn LB and Jeste DV: Enhancing informed consent for research
and treatment. Neuropsychopharmacology 24(6): 595-607, 2001.
270. Roepke S, McAdams LA, Lindamer LA, Patterson TL, Jeste DV:
Personality profiles among normal aged individuals as measured by
the NEO-PI-R. Aging and Mental Health 5(2): 159-164, 2001.
271. Patterson TL, Moscona S, Davidson K and Jeste DV: Social skills
performance assessment among older patients with schizophrenia.
Schizophrenia Research 48: 351-360, 2001.
272. Auslander LA, Lindamer LL, Delapena J, Harless K, Polichar D,
Patterson TL, Zisook S, Jeste DV: A comparison of community-dwelling
older schizophrenia patients by residential status. Acta
Psychiatrica Scandinavica 103: 380-386, 2001.
273. Sable JA, Jeste DV: Anxiety disorders in older adults. Current
Psychiatry Reports 3: 302-307, 2001.
274. Kasckow JW, Twamley E, Mulchahey JJ, Carroll B, Sabai M,
Strakowski SM, Patterson T, Jeste DV: Health-related quality of
well-being in chronically hospitalized patients with schizophrenia:
Comparison with matched outpatients. Psychiatry Research. 103(1):
69-78, 2001.
275. Lindamer LA, Lohr JB, Caligiuri MP, Jeste DV: Relationship of
gender and age of onset of schizophrenia to severity of dyskinesia.
Journal of Neuropsychiatry and Clinical Neurosciences. 13(3):
399-402, 2001.
276. Ashley RV, Gladsjo A, Olson R, Judd LL, Sewell DD, Rockwell ER,
Jeste DV: Changes in psychiatric diagnoses from admission to
discharge: Review of the charts of 159 patients consecutively
admitted to a geriatric psychiatry inpatient unit. General Hospital
Psychiatry. 23: 3-7, 2001.
277. Folsom DP, Jeste DV: Medical comorbidity in people with
schizophrenia. Home Health Care Consultant. 8(9): 17-21, 2001.
278. Patterson TL, Goldman S, McKibbin CL, Hughs T and Jeste DV:
UCSD Performance -Based Skills Assessment: Development of a new
measure of everyday functioning for severely mentally ill adults.
Schizophrenia Bulletin. 27(2): 235-245, 2001.
279. Dunn LB, Lindamer LA, Palmer BW, Schneiderman LJ, Jeste DV:
Enhancing comprehension of consent for research in older patients
with psychosis: A randomized study of a novel consent procedure.
American Journal of Psychiatry. 158(11): 1911-1913, 2001.
280. Jin H, Zisook S, Palmer BW, Patterson TL, Heaton RK and Jeste
DV: Association of depressive symptoms with worse functioning in
schizophrenia: A study of older outpatients. Journal of Clinical
Psychiatry 62 (10): 797-803, 2001.
281. Jeste DV: Editorial: Our journal in the new millennium.
American Journal of Geriatric Psychiatry 9: 327-329, 2001.
282. Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL,
Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins
PV, Small GW and Lieberman JA: National Institute of Mental Health -
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE):
Alzheimer’s Disease Trial Methodology. American Journal of Geriatric
Psychiatry 9: 346-360, 2001.
283. Jeste DV and Unutzer J: Guest Editorial: Improving the delivery
of care to the seriously mentally ill. Medical Care 39: 907-909,
2001.
284. Kasckow JW, Mohamed S, Thallasinos A, Carroll B, Zisook S and
Jeste DV: Citalopram augmentation of antipsychotic treatment in
older schizophrenia patients. International Journal of Geriatric
Psychiatry 16: 1163-1167, 2001.
285. Granholm E, McQuaid, JR, McClure FS, Pedrelli P and Jeste, DV:
A randomized controlled pilot study of cognitive behavioral social
skills training for older patients with schizophrenia. Schizophrenia
Research 53: 167-169, 2002.
286. Auslander LA, Perry W, Jeste DV: Assessing disturbed thinking
and cognition using the ego impairment index in older schizophrenia
patients: Paranoid vs. nonparanoid distinction. Schizophrenia
Research 53: 199-207, 2002.
287. Dolder CR, Lacro JP, Dunn LB, Jeste DV: Antipsychotic
medication adherence: Is there a difference between typical and
atypical agents? American Journal of Psychiatry 159: 103-108, 2002.
288. Patterson TL, Lacro J, McKibbin CL, Moscona S, Hughes T and
Jeste DV: Medication Management Ability Assessment: Results from a
performance-based measure in older outpatients with schizophrenia.
Journal of Clinical Psychopharmacology 22: 11-19, 2002.
289. Eyler Zorrilla L, Jeste DV, Brown GG: Functional MRI and Novel
Picture Learning among older patients with chronic schizophrenia:
Abnormal correlations between recognition memory and medial temporal
brain response. American Journal of Geriatric Psychiatry 10: 52-61,
2002.
290. Dunn LB, Lindamer LA, Palmer BW, Golshan S, Schneiderman LJ and
Jeste DV: Improving understanding of research consent in middle-aged
and elderly patients with psychotic disorders. American Journal of
Geriatric Psychiatry 10: 142-150, 2002.
291. Saks E, Dunn LB, Marshall BJ, Nayak GV, Golshan S and Jeste DV:
The California Scale of Appreciation: A new instrument to measure
the appreciation component of capacity to consent to research.
American Journal of Geriatric Psychiatry 10: 166-174, 2002.
292. Palmer BW, Nayak GV, Dunn LB, Appelbaum PS and Jeste DV:
Treatment-related decision making capacity in middle-aged and older
patients with psychosis: A preliminary study using the MacCAT-T and
HCAT. American Journal of Geriatric Psychiatry 10: 207-211, 2002.
293. Jin H, Meyer JM and Jeste DV: The phenomenology of and risk
factors for new-onset diabetes mellitus and diabetic ketoacidosis
associated with atypical antipsychotics: An analysis of 45 published
cases. Annals of Clinical Psychiatry 14: 59-64, 2002.
294. Saks ER, Jeste DV, Granholm E, Palmer BW, Schneiderman L:
Ethical issues in psychosocial interventions research involving
controls. Ethics and Behavior 12: 87-101, 2002.
295. Palmer BW, Heaton RK, Gladsjo JA, Evans JD, Patterson TL,
Golshan S, Jeste DV: Heterogeneity in functional status among older
outpatients with schizophrenia: Employment history, living
situation, and driving. Schizophrenia Research 55: 205-215, 2002.
296. Folsom D, Jeste DV: Schizophrenia in homeless persons: A
systematic review of the literature. Acta Psychiatrica Scandinavica
105: 404-413, 2002.
297. Kindermann SS, Dolder CR, Bailey A, Katz IR, Jeste DV:
Pharmacological treatment of psychosis and agitation in elderly
patients with dementia: Four decades of experience. Drugs and Aging
19: 257-276, 2002.
298. Sable JA and Jeste DV: Antipsychotic treatment for late-life
schizophrenia. Current Psychiatry Reports 4: 299-306, 2002.
299. Palmer BW, Folsom D, Bartels S and Jeste DV: Psychotic
disorders in late life: Implications for treatment and future
directions for clinical services. Generations 26: 29-43, 2002.
300. Auslander LA, Jeste DV: Perceptions of problems and needs for
service among older outpatients with schizophrenia and related
psychotic disorders. Community Mental Health Journal 38: 391-402,
2002.
301. Mamo DC, Sweet RA, Chengappa KNR, Reddy RR and Jeste DV: The
effect of age on pharmacological management of ambulatory patients
treated with depot neuroleptic medications for schizophrenia and
related psychotic disorders. International Journal of Geriatric
Psychiatry 17: 1012-1017, 2002.
302. Bartels SJ, Dums AR, Oxman TE, Schneider LS, Arean PA,
Alexopoulos GS and Jeste DV: Evidence-based practices in geriatric
mental health care. Psychiatric Services 53: 1419-1431, 2002.
303. Madhusoodanan S, Bogunovic OJ, Gupta S, Steinmeyer C, Brenner R
and Jeste DV: Use of atypical antispychotics in elderly patients
with schizophrenia and schizoaffective disorder. Journal of Advances
in Schizophrenia and Brain Research 4: 110-122, 2002.
304. Twamley EW, Doshi RR, Nayak G, Palmer BW, Golshan S, Heaton RK,
Patterson TL and Jeste DV: Generalized cognitive impairments,
ability to perform everyday tasks, and level of independence in
community living situations of older patients with psychosis.
American Journal of Psychiatry 159:2013-2020, 2002.
305. Folsom DP, McCahill M, Bartels SJ, Lindamder LA, Ganiats TG and
Jeste DV: Medical comorbidity and receipt of medial care by older
homeless persons with schizophrenia or depression. Psychiatric
Services 53:1456-1460, 2002.
306. Jeste DV, Twamley EW, Eyler Zorrilla LT, Golshan S, Patterson
TL and Palmer BW: Aging and outcome in schizophrenia. Acta
Psychiatrica Scandinavica 107: 336-343, 2003.
307. Lacro JP, Dunn LB, Dolder CR, Leckband SG and Jeste DV:
Prevalence of and risk factors for medication nonadherence in
patients with schizophrenia: A comprehensive review of recent
literature. Journal of Clinical Psychiatry 63: 892-909, 2003.
308. Dolder CR, Lacro JP and Jeste DV: Adherence to antipsychotic
and nonpsychiatric medications in middle-aged and older patients
with psychotic disorders. Psychosomatic Medicine 65: 156-162, 2003.
309. Patterson TL, McKibbin C, Taylor M, Goldman S, Davila-Fraga W,
Bucardo J and Jeste DV: Functional Adaptation Skills Training
(FAST): A pilot psychosocial intervention study in middle-aged and
older patients with chronic psychotic disorders. American Journal of
Geriatric Psychiatry 11: 17-23, 2003.
310. Palmer BW, Bondi MW, Twamley EW, Thal L, Golshan S, Jeste DV:
Are late-onset schizophrenia-spectrum disorders neurodegenerative
conditions?: Annual rates of change on two dementia measures.
Journal of Neuropsychiatry and Clinical Neurosciences 15: 45-52,
2003.
311. Eyler Zorrilla LT, Jeste DV, Paulus M, Brown GG: Functional
abnormalities of medial temporal cortex during novel picture
learning among patients with chronic schizophrenia. Schizophrenia
Research 59: 187-198, 2003.
312. Evans JD, Heaton RK, Paulsen JS, Palmer BW, Patterson T and
Jeste DV: The relationship of neuropsychological abilities to
specific domains of functional capacity in older schizophrenia
patients. Biological Psychiatry 53: 422-430, 2003.
313. Jeste DV: Editorial: The new and improved journal. American
Journal of Geriatric Psychiatry 11:118-119, 2003.
314. Lindamer LA, Buse DC, Auslander A, Unutzer J, Bartels SJ and
Jeste DV: A comparison of gynecological variables and services use
among older women with and without schizophrenia. Psychiatric
Services 54: 902-904, 2003.
315. Dolder CR and Jeste DV: Incidence of tardive dyskinesia with
typical versus atypical antipsychotics in very high risk patients.
Biological Psychiatry 53:1142-1145, 2003.
316. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S and
Jeste DV: Cognitive predictors of medication adherence among middle
aged and older outpatients with schizophrenia. Schizophrenia
Research 63:49-58, 2003.
317. Wetherell JL and Jeste DV: Diagnostic Decision Tree in
Dementia. Dialogues in Clinical Neuroscience 5:44-47, 2003.
318. Barrio C, Yamada A-M, Hough R, Hawthorne W, Garcia P and Jeste
DV: Ethnic disparities in use of public mental health care
management services among patients with schizophrenia. Psychiatric
Services 54:1264-1270, 2003.
319. Jin H, Folsom DP, Lindamer L, Bailey A, Hawthorne W, Garcia P
and Jeste DV: Patterns of public mental health service use by age in
patients with schizophrenia. American Journal of Geriatric
Psychiatry 11:525-533, 2003.
320. Dolder CR, Lacro JP, Leckband S and Jeste DV: Interventions to
improve antipsychotic medication adherence: Review of recent
literature. Journal of Clinical Psychopharmacology 23:389-399, 2003.
321. Jeste DV: A Wednesday in summer. Academic Psychiatry
27:202-204, 2003.
322. Katz IR, Jeste DV, Pollock BG and Tariot PN: Commentary:
Treating aggressive behavior in the elderly. Journal of Clinical
Psychiatry 64:S12-S16, 2003.
323. Lindamer LA, Bailey A, Hawthorne W, Folsom D, Gilmer TP, Garcia
P, Hough RL and Jeste DV: Gender differences in characteristics and
service use of public mental health patients with schizophrenia.
Psychiatric Services 54: 1407-1409, 2003.
324. Twamley EW, Jeste DV and Lehman, AF: Vocational rehabilitation
in schizophrenia and other psychotic disorders: A literature review
and meta-analysis of randomized controlled trials. The Journal of
Nervous and Mental Disease 191:515-523, 2003.
325. Twamley EW, Jeste DV and Bellack AS: A review of cognitive
training in schizophrenia. Schizophrenia Bulletin 29:359-382, 2003.
326. Cummings JL and Jeste DV: Pharmacotherapy of neuropsychiatric
syndromes in neurologic disorders: Definitional and regulatory
aspects. TEN: Trends in Evidence-based Neuropsychiatry 5:36-40,
2003.
327. Jeste DV and Palmer BW: The changing view of Alzheimer Disease.
TEN: Trends in Evidence-based Neuropsychiatry 5:32-35, 2003.
328. Wetherell JL, Palmer BW, Thorp S, Patterson TL, Golshan S and
Jeste DV: Anxiety symptoms and quality of life in middle-aged and
older outpatients with schizophrenia and schizoaffective disorder.
Journal of Clinical Psychiatry 23:1476-1482, 2003.
329. Jeste DV, Barak Y, Madhusoodanan S, Grossman F and Gharabawi G:
An international multisite double-blind trial of the atypical
antipsychotics risperidone and olanzapine in 175 eldelry patients
with chronic schizophrenia. American Journal of Geriatric Psychiatry
11:638-647, 2003.
330. Sciolla A, Patterson TL, McAdams LA, Wetherell J, Koch W, Jeste
DV: Functioning and well-being of middle-aged and older patients
with schizophrenia: Measurement with the 36-item short-form (SF-36)
health survey. American Journal of Geriatric Psychiatry 11:629-637,
2003.
331. Jeste DV, Dunn LB, Palmer BW, Saks E, Halpain M, Cook A,
Appelbaum P, and Schneiderman L: A collaborative model for research
on decisional capacity and informed consent in older patients with
schizophrenia: Bioethics Unit of a Geriatric Psychiatry Intervention
Research Center. Psychopharmacology 171:68-74, 2003.
332. Dunn LB and Jeste DV: Problem areas in the understanding of
informed consent for research: Study of middle-aged and older
patients with psychotic disorders. Psychopharmacology 171:81-85,
2003.
333. Sweet RA, Nimgaonkar VL, Devlin B and Jeste DV: Psychotic
symptoms in Alzheimer Disease: Evidence for a distinct phenotype.
Molecular Psychiatry 8:383-392, 2003.
334. Sable JA and Jeste DV: Pharmacologic management of psychosis in
the elderly. Journal of Nutrition, Health & Aging 7:421-427, 2003.
335. Gilmer TP, Folsom DP, Hawthorne W, Lindamer LA, Hough RL,
Garcia P and Jeste DV: Assisted living and use of health services
among Medicaid beneficiaries with schizophrenia. Journal of Mental
Health Economics and Policy 6:59-65, 2003.
336. Chiu E and Jeste, D: Identifying knowledge gaps and research
challenges in geriatric psychiatry. Current Opinion in Psychiatry
16:607-608, 2003.
337. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS,
Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand CP, Jeste DV,
Krishnan KRR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF, Rovner
BW, Steffens DC, Tariot PN, Unutzer J and Lebowitz BD: Provisional
diagnostic criteria for depression of Alzheimer Disease: Description
and review. Expert Review of Neurotherapeutics 3: 99-106, 2003.
338. Jeste DV and Nasrallah HA: Schizophrenia and aging: No more
dearth of data? (Editorial). American Journal of Geriatric
Psychiatry 11:584-587, 2003.
339. Woo BKP, Daly JW, Allen EC, Jeste DV and Sewell DD:
Unrecognized medical disorders in older psychiatric inpatients in a
Senior Behavioral Health Unit in a University Hospital. Journal of
Geriatric Psychiatry and Neurology 16:121-125; 2003.
340. Kennedy JS, Jeste DV, Kaiser CJ, Golshan S, Maguire GA,
Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore
JA, and Breier A: Olanzapine vs. haloperidol in geriatric
schizophrenia: Analysis of data from a double-blind controlled
trial. International Journal of Geriatric Psychiatry 18:1013-1020,
2003.
341. Jeste DV and Dolder CR: Treatment of non-schizophrenic
disorders: Focus on atypical antipsychotics. Journal of Psychiatric
Research 38:73-103, 2004.
342. Dolder CR, Patterson TL and Jeste DV: HIV, psychosis and aging:
Past, present and future. AIDS 18:S35-S42, 2004.
343. Evans EA and Jeste DV: William Carlos Williams. American
Journal of Geriatric Psychiatry 12:129-133, 2004.
344. Palmer BW, Dunn LB, Appelbaum PS and Jeste DV: Correlates of
treatment-related decision making capacity among middle-aged and
older patients with schizophrenia. Archives of General Psychiatry
61:230-236, 2004.
345. Wetherell JL, Thorp SR, Patterson TL, Golshan S, Jeste DV, Gatz
M: Quality of life in geriatric generalized anxiety disorder: A
preliminary investigation. Journal of Psychiatric Research 38:
305-312, 2004.
346. Gilmer TP, Dolder CR, Lacro JP, Folsom D, Lindamer L, Garcia P
and Jeste DV: Adherence to treatment with antipsychotic medication
and health care costs among Medicaid beneficiaries with
schizophrenia. American Journal of Psychiatry 161: 692-699, 2004.
347. Kindermann SS, Brown GG, Eyler Zorrilla L, Olsen RK and Jeste
DV: Spatial working memory among middle-aged and older patients with
schizophrenia and volunteers using fMRI. Schizophrenia Research
68:203-216, 2004.
348. Kim SYH, Appelbaum PS, Jeste DV and Olin J: Proxy and surrogate
consent in geriatric neuropsychiatric research: Update and
recommendations. American Journal of Psychiatry 161: 797-806, 2004.
349. Eyler LT, Olsen RK, Jeste DV and Brown GG: Abnormal brain
response of chronic schizophrenia patients despite normal
performance during a visual vigilance task. Psychiatry Research
Neuroimaging 130: 245-257, 2004.
350. McKibbin C, Patterson TL and Jeste DV: Assessing disability in
older patients with schizophrenia: Results from the WHODAS-II.
Journal of Nervous and Mental Disease 192: 405-413, 2004.
351. Jeste DV: Tardive dyskinesia rates with atypical antipsychotics
in older patients. Journal of Clinical Psychiatry 65: 21-24, 2004.
352. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO and Jeste
DV: Brief Evaluation of Medication Influences and Beliefs (BEMIB):
Development and testing of a brief scale for medication adherence.
Journal of Clinical Psychopharmacology 24: 404-409, 2004.
353. Moore DJ, Palmer BW and Jeste DV: Use of Mini-Mental State Exam
in middle-aged and older outpatients with schizophrenia: Cognitive
impairment and its associations. American Journal of Geriatric
Psychiatry 12: 412-419, 2004.
354. Jeste DV: Lifetime influence of one year with Gerry Smith.
Physiology and Behavior 82: 167-170, 2004.
355. Auslander LA and Jeste DV: Sustained remission of schizophrenia
among community-dwelling older outpatients. American Journal of
Psychiatry 161:1490-1493, 2004.
356. Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V and
Liu-Seifert H: Olanzapine treatment for tardive dyskinesia in
schizophrenia patients: A prospective clinical trial with patients
randomized to blinded dose reduction periods. Progress in
Neuro-Psychopharmacology and Biological Psychiatry 28:985-996, 2004.
357. Jeste ND, Palmer BW and Jeste DV: Historical Case Conference:
Tennessee Williams. American Journal of Geriatric Psychiatry
12:370-375, 2004.
358. Jin H, Meyer JM, and Jeste DV: Atypical antipsychotics and
glucose dysregulation: A systematic review. Schizophrenia Research
71:195-212, 2004.
359. Folsom DP, Nayak GV, and Jeste DV: Antipsychotic medications
and the elderly. Primary Psychiatry 11: 47-50, 2004.
360. Depp CA and Jeste DV: Bipolar disorder in older adults: A
critical review. Bipolar Disorders 6: 343-367, 2004.
361. Woo BKP, Rice VA, Legendre SA, Salmon DP, Jeste DV and Sewell
DD: The clock drawing test as a measure of executive dysfunction in
elderly depressed patients. Journal of Geriatric Psychiatry and
Neurology, 17:190-294, 2004.
362. Caligiuri M and Jeste DV: Association of diabetes with
dyskinesia in older psychosis patients. Psychopharmacology
176:281-286, 2004.
363. Depp CA, Jin H, Mohamed S, Kaskow J, Moore J, and Jeste DV:
Bipolar disorder in middle aged and elderly adults: Is age of onset
important? The Journal of Nervous and Mental Disease 192:796-799,
2004.
364. Pedrelli P, McQuaid JR, Granholm E, Patterson TL, McClure F,
Beck AT, and Jeste DV: Measuring cognitive insight in middle-aged
and older patients with psychotic disorders.
Schizophrenia Research 71:297-305, 2004.
365. Gladsjo JA, McAdams LA, Palmer BW, Moore D, Jeste DV, and
Heaton RK: A six-factor model of cognition in schizophrenia and
related psychotic disorders: Relationships with clinical symptoms
and functional capacity. Schizophrenia Bulletin 30:739-754, 2004.
366. McKibbin CL, Brekke JS, Sires D, Jeste DV, and Patterson TL:
Direct assessment of functional abilities: Relevance to persons with
schizophrenia. Schizophrenia Research 72:53-67, 2005.
367. Folsom DP, Hawthorne W, Lindamer L, Gilmer T, Bailey A, Golshan
S, Garcia P, Unutzer J, Hough R and Jeste DV: Prevalence and risk
factors for homelessness and utilization of mental health services
amont 10,340 patients with serious mental illness in a large public
mental health system. American Journal of Psychiatry 162: 370-376,
2005.
368. Jeste DV: Feeling fine at hundred and three: Secrets of
successful aging. American Journal of Preventive Medicine
28:323-324, 2005.
369. Halpain MC, Trinidad GI, Wetherell JL, Lebowitz BD and Jeste
DV: Intensive short-term research training for undergraduate,
graduate, and medical students: Early experience with a new
national-level approach in geriatric mental health. Academic
Psychiatry 29:58-65, 2005.
370. Martin JL, Jeste DV, and Ancoli-Israel S: Older schizophrenia
patients have more disrupted sleep and circadian rhythms than
age-matched comparison subjects. Journal of Psychiatric Research
39:251-259, 2005.
371. Jeste DV: Another milestone: The Journal goes monthly
(Editorial). American Journal of Geriatric Psychiatry 13:1-2, 2005.
372. Dolder CR, Furtek K, Lacro JP, Jeste DV: Antihypertensive
medication adherence and blood pressure control in patients with
psychotic disorders compared to persons without psychiatric illness.
Psychosomatics 46:135-141, 2005.
373. Granholm E, Periveliotis D, McQuaid JR, Auslander LA, McClure
FS, Pedrelli P, Patterson T, and Jeste DV: A randomized controlled
trial of cognitive behavioral social skills training for middle-aged
and older outpatients with chronic schizophrenia. American Journal
of Psychiatry 162:520-529, 2005.
374. Eyler LT, Mirzakhanian H and Jeste DV: A preliminary study of
interactive questioning methods to assess and improve understanding
of informed consent amont patients with schizophrenia. Schizophrenia
Research 75:193-198, 2005.
375. Depp CA, Lindamer LA, Folsom DP, Gilmer T, Hough RL, Garcia P,
and Jeste DV: Differences in clinical features and mental health
service use in bipolar disorder across the life span. American
Journal of Geriatric Psychiatry 13:290-298, 2005.
376. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R,
Golshan S, and Jeste DV: Assessment of capacity to consent to
research among older persons with schizophrenia, Alzheimer disease,
or diabetes mellitus: Comparison of a three-item questionnaire with
a comprehensive standardized instrument. Archives of General
Psychiatry 62:726-733, 2005.
377. Jeste DV, Blazer D, and First M: Aging-related diagnostic
variations: Need for diagnostic criteria appropriate for elderly
psychiatric patients. Biological Psychiatry 58:265-271, 2005.
378. Davis CE, Jeste DV, and Eyler LT: Review of longitudinal
neuroimaging studies of drug treatments in patients with
schizophrenia. Schizophrenia Research 78:45-60, 2005.
379. Twamley EW, Padin D, Bayne K, Narvaez J, Williams R and Jeste
DV: Work rehabilitation for older people with schizophrenia: A
comparison of three approaches. The Journal of Nervous and Mental
Disease 193:596-601, 2005.
380. Jeste DV, Dolder CR, Nayak GV, and Salzman C: Atypical
antipsychotics in elderly patients with dementia or schizophrenia:
Review of recent literature. Harvard Review of Psychiatry
13:340-351, 2005.
381. Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste DV,
Kim S, Keefe R, Manschreck T, McEvoy J and Lieberman:
Decision-making capacity for research participation among
individuals in the CATIE schizophrenia trial. Schizophrenia Research
80:1-8, 2005.
382. De Deyn P, Jeste DV, Swanink R, Kostic D, and Breder C:
Aripiprazole for the treatment of psychosis in patients with
Alzheimer’s disease: A randomized, placebo-controlled study. Journal
of Clinical Psychopharmacology 25:463-467, 2005.
383. Ropacki S and Jeste DV: Epidemiology of and risk factors for
psychosis of Alzheimer Disease: A review of 55 studies published
from 1990 to 2003. American Journal of Psychiatry 162:2022-2030,
2005.
384. Van Critters AD, Pratt SI, Bartels SJ and Jeste DV:
Evidence-based review of pharmacologic and nonpharmacologic
treatments for older adults with schizophrenia. Psychiatric Clinics
of North America 28:913-939, 2005.
385. Patterson TL, Bucardo J, McKibbin CL, Mausbach BT, Moore D,
Barrio C, Goldman SR, and Jeste DV: Development and pilot testing of
a new psychosocial intervention for older Latinos with chronic
psychosis. Schizophrenia Bulletin 31:922-930, 2005.
386. Montross LP, Barrio C, Yamada A-M, Lindamer L, Golshan S,
Garcia P, Fuentes D, Hough RL and Jeste DV: Tri-ethnic variations of
co-morbid substance and alcohol use disorders in schizophrenia.
Schizophrenia Research 79:297-305, 2005.
387. Jeste ND, Moore DJ, Goldman S, Bucardo J, Davila-Fraga W,
Golshan S, Jeste DV, and Patterson TL: Predictors of everyday
functioning among older Mexican-Americans vs. Anglo-Americans with
schizophrenia. Journal of Clinical Psychiatry 66:1304-1311, 2005.
388. Palmer BW and Jeste DV: Relationship of individual cognitive
abilities to specific components of decisional capacity among
middle-aged and older patients with schizophrenia. Schizophrenia
Bulletin 32:98-106, 2006.
389. Jeste DV, Depp CA, and Palmer BW: Magnitude of impairment in
decisional capacity in people with schizophrenia compared to normal
subjects: An overview. Schizophrenia Bulletin 32:121-128, 2006.
390. Jeste DV: Editorial: Entering the 14th year: The AJGP continues
to grow. American Journal of Geriatric Psychiatry 14:1, 2006.
391. Depp C and Jeste DV: Definitions and predictors of successful
aging: A comprehensive review of the literature. American Journal of
Geriatric Psychiatry 14:6-20, 2006.
392. Montross LP, Depp C, Daly J, Reichstadt J, Golshan S, Moore D,
Sitzer D, and Jeste, DV: Correlates of successful aging among
community-dwelling older adults. American Journal of Geriatric
Psychiatry 14:43-51, 2006.
393. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV: The
health-related quality of life and functioning of middle-aged and
elderly adults with bipolar disorder. Journal of Clinical Psychiatry
67:215-221, 2006.
394. Dunn LB, Palmer BW, Keehan M, Jeste DV, and Appelbaum PS:
Assessment of therapeutic misconception in older schizophrenia
patients using a brief instrument. American Journal of Psychiatry
163:500-506, 2006.
395. Nayak-Salva G, Moore DJ, Roesch SC, Heaton RK, Jeste DV and
Palmer BW: An evaluation of longitudinal neurocognitive performance
among middle-aged and older schizophrenia patients: Use of
mixed-model analyses. Schizophrenia Research 83:215-223, 2006.
396. Twamley ET, Narvaez JM, Sadek JR, Jeste DV, Grant I, and Heaton
RK: Work-related abilities in schizophrenia and HIV infection. The
Journal of Nervous and Mental Disease 194:268-274, 2006.
397. Jeste DV: Can medication-free research ever be ethical in older
people with psychotic disorders? Schizophrenia Bulletin 32:303-304,
2006.
398. Mittal D, Davis CE, Depp C, Pyne JM, Golshan S, Patterson TL,
Jeste DV: Correlates of health-related quality of well-being in
older patients with schizophrenia. Journal of Nervous and Mental
Disease 194:335-340, 2006.
399. Yamada AM, Barrio C, Morrison SW, Sewell D, Jeste DV:
Cross-ethnic evaluation of psychotic symptom content in hospitalized
middle-aged and older adults. General Hospital Psychiatry 28:161-8,
2006.
400. Kryzhanovskaya LA, Jeste DV, Young C, Polzer J, Roddy T, Jansen
J, Carlson J, and Cavazzoni P: A review of treatment-emergent
adverse events during olanzapine clinical trials in elderly patients
with dementia. Journal of Clinical Psychiatry 67:933-945, 2006.
401. Yamada AM, Valle R, Barrio C and Jeste DV: Selecting an
acculturation measure for use with Latino older adults. Research on
Aging 28:519-561, 2006.
402. Sitzer DI, Twamley EW and Jeste DV: Cognitive training in
Alzheimer disease: A metaanalysis of the literature. Acta
Psychiatrica Scandinavica 114:75-90, 2006.
403. Saks ER and Jeste DV: Capacity to consent to or refuse
treatment and/or research: Theoretical considerations. Behavioral
Sciences and the Law 24:411-429, 2006.
404. Eyler LT and Jeste DV: Enhancing the informed consent process:
A conceptual overview. Behavioral Sciences and the Law 24: 553–568,
2006.
405. Jeste DV and Saks ER: Decisional capacity in mental illness and
substance use disorders: Empirical database and policy implications.
Behavioral Sciences and the Law 24:607-628, 2006.
406. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, and Saks ER:
Assessing decisional capacity for clinical research or treatment: A
review of instruments. American Journal of Psychiatry 163:1323-1334,
2006.
407. Jeste DV, Meeks TW, Kim DS and Zubenko GS: Research agenda for
DSM-V: Diagnostic categories and criteria for neuropsychiatry
syndromes in dementia. Journal of Geriatric Psychiatry and Neurology
19:160-71, 2006.
408. Patterson TL, McKibbin C, Mausbach BT, Goldman S, Bucardo J and
Jeste DV: Functional Adaptation Skills Training (FAST): A randomized
trial of a psychosocial intervention for middle-aged and older
patients with chronic psychotic disorders. Schizophrenia Research
86:291-299, 2006.
409. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch
S, Mudaliar S, Barrio C, O’Hanlon K, Griver K, Sirkin A, and Jeste
DV: A lifestyle intervention for older schizophrenia patients with
Diabetes Mellitus: A randomized controlled trial. Schizophrenia
Research 86: 36-44, 2006.
410. Mohamed S, Bondi MW, Kasckow JW, Golshan S, and Jeste DV:
Neurocognitive functioning in dually diagnosed middle aged and
elderly patients with alcoholism and schizophrenia. International
Journal of Geriatric Psychiatry 21:711-718, 2006.
411. Twamley EW, Palmer BW, Jeste DV and Heaton RK: Transient and
executive function working memory in schizophrenia. Schizophrenia
Research 87:185-190, 2006.
412. Meeks TW, Ropacki SA and Jeste DV: The neurobiology of
neuropsychiatric syndromes in dementia. Current Opinion in
Psychiatry 19:581-586, 2006.
413. Chiu E and Jeste DV: Efficacy and Cost-Effectiveness in
dementia interventions – The need for an international consensus.
Current Opinion in Psychiatry 19:553-554, 2006.
414. Haupt M, Cruz-Jentoft A, and Jeste DV: Mortality in elderly
dementia patients treated with risperidone. Journal of Clinical
Psychopharmacology 26:566-570, 2006.
415. Li C, Wu W, Jin H, Zhang X, Xue H, He Y, Xiao S, Jeste DV and
Zhang M: Successful aging in Shanghai, China: Definition,
distribution and related factors. International Psychogeriatrics
18:551-563, 2006.
416. Folsom DP, Lindamer L, Montross L, Hawthorne W, Golshan S,
Hough R, Shale J, and Jeste DV: Diagnostic variability for
schizophrenia and major depression in a large public mental
healthcare system district. Psychiatry Research 144:167-175, 2006.
417. Gilmer T, Ojeda VD, Folsom D, Fuentes D, Garcia P and Jeste DV:
Costs of community-based public mental health services for older
adults: Variations related to age, ethnicity, and diagnosis.
International Journal of Geriatric Psychiatry 21:1121-1126, 2006.
418. Moore DJ, Savla GN, Woods SP, Jeste DV, and Palmer BW: Verbal
fluency impairments among community-dwelling, middle-aged and older
adults with schizophrenia are characterized by deficient switching.
Schizophrenia Research 87:254-260, 2006.
419. Woo BKP, Golshan S, Allen EC, Daly JW, Jeste DV and Sewell DD:
Factors associated with frequent admissions to an acute geriatric
psychiatric inpatient unit. Journal of Geriatric Psychiatry and
Neurology 19:226-230, 2006.
420. Woods SP, Twamley EW, Dawson MS, Narvaez JM and Jeste DV:
Deficits in cue detection and intention retrieval underlie
prospective memory impairment in schizophrenia. Schizophrenia
Research 90:344-350, 2007.
421. Moore DJ, Palmer BW, Patterson TL and Jeste DV: A review of
performance-based measures of functional living skills. Journal of
Psychiatric Research 41:97-118, 2007.
422. Jeste DV, Halpain M, Trinidad G, Reichstadt J, and Lebowitz BD:
UCSD’s short-term research training programs for trainees at
different levels of career development. Academic Psychiatry
31:160-167, 2007.
423. Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C,
Golshan S, Blevins D, and Jeste DV: Comparison of two enhanced
consent procedures for patients with mild Alzheimer Disease or mild
cognitive impairment. American Journal of Geriatric Psychiatry
15:163-167, 2007.
424. Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, and Jeste
DV: Prevalence and correlates of adequate performance on a measure
of abilities related to decisional capacity: differences among three
standards for the MacCAT-CR in patients with schizophrenia.
Schizophrenia Research 89:110-118, 2007.
425. Reichstadt J, Depp CA, Palinkas LA, Folsom DP and Jeste DV:
Building blocks of successful aging: A focus group study of older
adults’ perceived contributors to successful aging. American Journal
of Geriatric Psychiatry 15:194-201, 2007.
426. Palmer BW, Dunn LB, Depp C, Eyler LT, and Jeste DV: Decisional
capacity to consent to research among patients with bipolar
disorder: Comparison with schizophrenia patients and healthy
subjects. Journal of Clinical Psychiatry 68:689-696, 2007.
427. Palinkas LA, Criado V, Fuentes D, Shepherd S, Milian H, Folsom
D, and Jeste DV: Unmet needs for services for older adults with
mental illness: Comparison of views of different stakeholder groups.
American Journal of Geriatric Psychiatry 15:530-540, 2007.
428. Gilmer TP, Dolder CR, Folsom DP, Mastin W and Jeste DV:
Antipsychotic polypharmacy trends Medi-Cal beneficiaries with
schizophrenia in San Diego County, 1999–2004. Psychiatric Services
58:1007-1010, 2007.
429. Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn
LB, Kim K, Meeks T, Kraemer HC: A new brief instrument for assessing
decisional capacity for clinical research. Archives of General
Psychiatry 64:966-974, 2007.
430. Folsom DP, Gilmer T, Barrio C, Moore DJ, Bucardo J, Lindamer
LA, Garcia P, Hawthorne W, Hough R, Patterson T, and Jeste DV: A
longitudinal study of the use of mental health services by persons
with serious mental illness: Spanish-speaking Latinos differ from
English-speaking Latinos and Caucasians. American Journal of
Psychiatry 164:1173-1180, 2007.
431. Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, and Jeste DV:
Successful aging: From phenotype to genotype. Biological Psychiatry
62:282-293, 2007.
432. Jeste DV and Meeks T: To prescribe or not to prescribe?
Atypical antipsychotic drugs in patients with dementia. Southern
Medical Journal 100:961-3, 2007.
433. Meeks TW, Wetherell J, Irwin MR and Jeste DV: Complementary and
alternative treatments for late-life depression, anxiety, and sleep
disturbance: A review of randomized controlled trials. Journal of
Clinical Psychiatry 68:1461-71, 2007.
434. Meeks TW and Jeste DV: Complementary and alternative medicine
(CAM) use in geriatric psychiatry clinics. Journal of Alternative
and Complementary Medicine 13:705-7, 2007.
435. Loebach Wetherell J, Kim DS, Lindamer LA, Thorp SR, Hawthorne
W, Kim K, Hough RL, Garcia P and Jeste DV: Anxiety disorders in a
public mental health system: Clinical characteristics and service
use patterns.J Affect Disord 104:179-83, 2007.
436. Jeste DV, Dunn LB, Folsom DP, and Zisook D: Multimedia
educational aids for improving consumer knowledge about illness
management and treatment decisions: A review of randomized
controlled trials. Journal of Psychiatric Research 42:1-21, 2007.
437. Moore DJ, Sitzer D, Depp CA, Montross LP, Reichstadt J,
Lebowitz BD and Jeste DV: Self-administered cognitive screening of a
community-dwellling successfully aging cohort. International Journal
of Geriatric Psychiatry 22:327-31, 2007.
438. Depp CA, Moore DJ, Sitzer D, Palmer BW, Lebowitz BD, Eyler LT,
Roesch S, and Jeste DV: Neurocognitive impairment in middle-aged and
elderly adults with bipolar disorder: Comparison to schizophrenia
and normal comparison subjects. Journal of Affective Disorders
101:201-9, 2007.
439. Mausbach BT, Harvey PD, Goldman S, Jeste DV and Patterson TL:
Development of a brief scale of everyday functioning in persons with
serious mental illness. Schizophrenia Bulletin 33:1364-72, 2007.
440. Eyler LT, Olsen RK, Nayak GV, Mirzakhanian H, Brown GG, and
Jeste DV: Brain response correlates of decisional capacity in
schizophrenia: a preliminary FMRI study. Journal of Neuropsychiatry
and Clinical Neuroscience 19:137-44, 2007.
441. Depp CA, Lebowitz BD, Patterson TL, Lacro JP, and Jeste DV:
Medication adherence skills training for middle-aged and elderly
adults with bipolar disorder: Development and pilot study. Bipolar
Disorders 9:636-45, 2007.
442. Granholm E, McQuaid JR, McClure FS, Link P, Perivoliotis D,
Gottlieb JD, Patterson T and Jeste DV: Randomized controlled trial
of cognitive behavioral social skills training for older people with
schizophrenia: 12-month follow-up. Journal of Clinical Psychiatry
68:730-7, 2007.
443. Kim SYH, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC,
Jeste DV, Lamberti JS, Leibovici A and Caine ED: Determining when
impairment constitutes incapacity for informed consent in
schizophrenia research. British Journal of Psychiatry 191:38-43,
2007.
444. Depp C, Glatt SJ and Jeste DV: Recent advances in research on
successful or healthy aging. Current Psychiatry Reports 9:7-13,
2007.
445. Chiu E and Jeste DV: Publication of the International
Psychogeriatric Association consensus statement on defining and
measuring treatment benefits in dementia. Current Opinion in
Psychiatry 20:531-532, 2007.
446. Gilmer T, Ojeda V, Folsom D, Fuentes D, Garcia P and Jeste DV:
Initiation and use of public mental health services by persons with
severe mental illness and limited english proficiency. Psychiatric
Services 58:1555-1562, 2007.
447. Eyler LT, Jeste DV and Brown GG: Brain response abnormalities
during verbal learning among patients with schizophrenia. Psychiatry
Research: Neuroimaging 162:11-25, 2008.
448. Mausbach BT, Cardenas V, McKibbin CL, Jeste DV and Patterson
TL: Reducing emergency medical service use in patients with chronic
psychotic disorders: results from the FAST intervention study.
Behaviour Research and Therapy 46:145-153, 2008.
449. Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste
DV and Patterson TL: Usefulness of the UCSD Performance-based
Assessment (UPSA) for predicting residential independence in
patients with chronic schizophrenia. Journal of Psychiatric Research
42:320-327, 2008.
450. Mausbach BT, Budardo J, McKibbin CL, Cardenas V and Barrio C:
Evaluation of a culturally tailored skills intervention for Latinos
with persistent psychotic disorders. American Journal of Psychiatric
Rehabilitation 11:61-75, 2008.
451. Jin H, Meyer JM, Mudaliar S and Jeste DV: Impact of atypical
antipsychotic therapy on leptin, ghrelin, and adiponectin.
Schizophrenia Research 100:70-85, 2008.
452. Granholm E, McQuaid JR, Link, PC, Fish S, Patterson T and Jeste
DV: Neuropsychological predictors of functional outcome in cognitive
behavioral social skills training for older people with
schizophrenia. Schizophrenia Research 100:133-143, 2008.
453. Twamley, EW, Narvaez, JM, Becker, DR, Bartels, SJ, & Jeste, DV:
Supported employment for middle-aged and older people with
schizophrenia. American Journal of Psychiatric Rehabilitation
11:76-89, 2008.
454. Lindamer LA, Lebowitz BD, Hough RL, Garcia P, Aquirre A,
Halpain MC, Depp C and Jeste DV: Improving care for older persons
with schizophrenia through an Academic-Community Partnership.
Psychiatric Services 59:236-239, 2008.
455. Jeste DV, Blazer D, Casey DE, Meeks T, Salzman C, Schneider L,
Tariot P and Yaffe K: ACNP White Paper: Update on the use of
antipsychotic drugs in elderly persons with dementia.
Neuropsychopharmacology 33:957-970, 2008.
456. Sitzer DI, Twamley EW, Patterson TL, and Jeste DV: Multivariate
predictors of social skills performance in middle-aged and older
outpatients with schizophrenia spectrum disorders. Psychological
Medicine 2007 Sep 6; [Epub ahead of print].
457. Barrio C, Garcia P, Palinkas LA, Yamada A-M, Fuentes D, Criado
V and Jeste DV: Unmet needs for mental health services for Latino
older adults: Perspectives from consumers, family members,
advocates, and service providers. Community Mental Health Journal
2007 Nov 17; [Epub ahead of print].
458. Delano-Wood L, Houston WS, Emond JA, Marchant NL, Salmon DP,
Jeste DV, Thal LJ, and Bondi MW: APOE genotype predicts depression
in women with Alzheimer’s Disease: A retrospective study.
International Journal of Geriatric Psychiatry 2007 Dec 3; [Epub
ahead of print].
459. Bucardo J, Patterson TL and Jeste DV: Cultural formulation with
attention to language and cultural dynamics in a Mexican psychiatric
patient treated in San Diego, USA. Culture, Medicine, and Psychiatry
2008 Jan 8; [Epub ahead of print].
460. Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T,
Glorioso D, Fellows I, Kraemer H and Appelbaum PS: Multimedia
consent for research in people with schizophrenia and normal
subjects: a randomized controlled trial. Schizophrenia Bulletin 2008
Jan 31; [Epub ahead of print].
461. Folsom DP, McKibbin C, Jeste DV, and Patterson T: Use of
primary care by middle aged and older persons with schizophrenia.
Primary Care and Community Psychiatry (in press, 2008).
462. Depp CA, Savla GN, Moore DJ, Palmer BW, Stricker JL, Lebowitz
BD and Jeste DV: Short-term course of neuropsychological abilities
in middle-aged and older adutlts with bipolar disorder. Bipolar
Disorders (in press, 2008).
463. Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J,
Grossberg G, Jarvik L, Kraemer H, Lebowitz B, Maslow K, Pollock B,
Raskind M, Schultz S, Wang P, Zito JM and Zubenko GS: Elderly
patients with dementia-related symptoms of severe agitation and
aggression: Consensus statement on treatment options, clinical
trials methodology, and policy. Journal of Clincial Psychiatry (in
press, 2008).
464. Twamley EW, Woods SP, Zurhellen CH, Vertinski M, Narvaez JM,
Mausbach BT, Patterson TL and Jeste DV: Neuropsychological
substrates and everyday functioning implications of prospective
memory impairment in schizophrenia. Schizophrenia Research (in
press, 2008).
465. Jeste DV and Vahia I: Comparison of the conceptualization of
wisdom in ancient Indian literature with modern views: Focus on the
Bhagavad Gita. Psychiatry (in press, 2008).
466. Lamond AJ, Depp C, Allison M, Langer R, Reichstadt J, Moore DJ,
Golshan S, Ganiats TG and Jeste DV: Measurement and predictors of
resilience among community-dwelling older women. Journal of
Psychiatric Research (in press, 2008).
467. Meeks TW and Jeste DV: Beyond the black box: what is the role
for antipsychotics in dementia. Current Psychiatry (in press, 2008).
468. Twamley EW, Savla GN, Zurhellen CH, Heaton RK, and Jeste DV:
Development and pilot testing of a novel compensatory cognitive
training intervention for people with psychosis. American Journal of
Psychiatric Rehabilitation (in press, 2008).
469. Eyler LT, Kaup AR, Mirzakanian H and Jeste DV: Schizophrenia
patients lack normal positive correlation between age and brain
response during verbal learning. American Journal of Geriatric
Psychiatry (in press, 2008).
470. McKibbin CL, Trenova-Oliver L, Golshan S, Patterson TL,
Lebowitz B, Shepherd S and Jeste DV: Stigma-Related functional
disability in middle-aged and older persons with schizophrenia.
American Journal of Geriatric Psychiatry (submitted, 2008).
Invited Book Chapters
1. Vahia NS, Doongaji DR and Jeste DV:
Psychological medicine. In: Textbook of Medicine. Second Edition.
Vakil RJ (ed). Bombay: Association of Physicians of India, 1973, pp.
1476 1498.
2. Vahia NS, Doongaji DR and Jeste DV: Value of Patanjali's concepts
in the treatment of Psychoneurosis. In: New Dimensions in
Psychiatry: A World View. S Arieti and G Chrzanowski (eds). New
York: John Wiley and Sons. pp. 293-304, 1975.
3. Rosenblatt JE, Pary RJ, Bigelow LB, DeLisi LE, Wagner RL,
Kleinman JE, Weinberger DR, Potkin SG, Shiling D, Jeste DV,
Alexander P and Wyatt RJ: Measurement of serum neuroleptic
concentrations by radioreceptor assay: Concurrent assessment of
clinical response and toxicity. In: Neuroreceptors Basic and
Clinical Aspects. E Usdin, WE Bunney and JM Davis (eds). New York:
John Wiley and Sons, Ltd. pp. 165-188, 1981.
4. Potkin SG, Jeste DV, Karoum F, Doongaji DR, Apte JS, Sheth AS,
Chuang L W and Wyatt RJ: A cross cultural design to test a
biological hypothesis of schizophrenia. In: Biological Markers in
Psychiatry and Neurology. E Usdin and I Hanin (ed). New York:
Pergamon Press. pp. 49 59, 1982.
5. Wyatt RJ, Cutler NR, DeLisi LE, Jeste DV, Kleinman JE, Luchins
DJ, Potkin SG and Weinberger DR: Biochemical and morphological
aspects of schizophrenia. In: APA Annual Review. L Grinspoon (ed).
Washington, DC: American Psychiatric Press. pp. 112 153, 1982.
6. Jeste DV, Jeste SD and Wyatt RJ: Reversible tardive dyskinesia:
Implications for therapeutic strategy and prevention of tardive
dyskinesia. In: New Directions in Tardive Dyskinesia Research. J
Bannet and RH Belmaker (eds). Basel: S Karger. pp. 34 48, 1983.
7. Jeste DV and Wyatt RJ: Neuroleptic induced tardive dyskinesia.
In: New Psychiatric Syndrome: DSM III and Beyond. S Akhtar (ed). New
York: Jason Aronson, Inc. pp.313 338, 1983.
8. Jeste DV, Karson CN and Wyatt RJ: Movement disorder and
psychopathology. In: Neuropsychiatric Movement Disorders. Jeste DV
and Wyatt RJ (eds). Washington, DC: American Psychiatric Press.
pp.119-150, 1984.
9. Jeste DV, Grebb J and Wyatt RJ: Psychiatric aspects of movement
disorders and demyelinating diseases. In: Psychiatry Update, Vol. 4.
AJ Frances and RE Hales (eds). Washington, DC: American Psychiatric
Press. pp.159 189, 1985.
10. Jeste DV, Wisniewski A and Wyatt RJ: Neuroleptic associated "tardive"
syndromes. In: Schizophrenia: The Psychiatric Clinics of North
America. A Roy (ed). New York: Plenum Press. Vol. 9:1:183 192, 1986.
11. Jeste DV, Kaufmann CA and Wyatt RJ: Tardive dyskinesia and
subtyping of schizophrenia. In: Movement Disorders. NS Shah and A
Donald (eds). New York: Plenum Publishing Corporation. pp. 149 157,
1986.
12. Lohr J, Wisniewski A and Jeste DV: Neurological aspects of
tardive dyskinesia. In: The Neurology of Schizophrenia. HA Nasrallah
and DR Weinberger (eds). Amsterdam: Elsevier Science Publishers. pp.
97 119, 1986.
13. Jeste DV, Lohr JB, Mani RB, Cadel JL and Ludwig C: Neuronal loss
in normal aging and neuropsychiatric dementias. In: Neuropsychiatric
Dementias: Current Perspectives. DV Jeste (ed). Washington, DC:
American Psychiatric Press. pp. 111-143, 1986.
14. Jeste DV, Lohr JB, Kaufmann CA and Wyatt RJ: Pathophysiology of
tardive dyskinesia: Evaluation of supersensitivity theory and
alternative hypotheses. In: Tardive Dyskinesia: From Dogma to
Reason. D Casey and G Gardos (eds). Washington, DC: American
Psychiatric Press. pp. 15-32, 1986.
15. Jeste DV, Lohr JB and Mani R: Quantitative neuropathology and
aging. In: Biological Psychiatry 1985. C Shagass, RC Josiassen, WH
Bridger, KJ Weiss, D Stoff and GM Simpson (eds.). New York: Elsevier
Science Publishers, pp. 1409-1411, 1986.
16. Lohr JB and Jeste DV: Studies of cerebellum and hippocampus in
major psychiatric disorders. In: Biological Psychiatry 1985. C
Shagass, RC Josiassen, WH Bridger, KJ Weiss, D Stoff and GM Simpson
(eds). New York: Elsevier Science Publishers, pp. 1024-1026, 1986.
17. Jeste DV, Lohr JB, Cadet JL and Wyatt RJ: Tardive dyskinesia:
Neurological mechanisms. In: Biological Psychiatry 1985. C Shagass,
RC Josiassen, WH Bridger, KJ Weiss, D Stoff and GM Simpson (eds.).
New York: Elsevier Science Publishers, pp. 1205-1207, 1986.
18. Jeste DV, Iager A and Wyatt RJ: Biologic and therapeutic aspects
of tardive dyskinesia and related movement disorders. In: American
Handbook of Psychiatry, Vol. 8. PA Berger and HK Brodie (eds). New
York: Basic Books. pp. 536-580, 1986.
19. Jeste DV and Lohr JB: Behavioral genetics. In: Behavioral
Science. G Wiener (ed). New York: John Wiley and Sons, pp. 63-70,
1987.
20. Lohr JB, Kaufmann CA and Jeste DV: Biochemistry of behavior. In:
Behavioral Science. G Wiener (ed). New York: John Wiley and Sons,
pp. 13-26, 1987.
21. Jeste DV and Wyatt RJ: Aging and tardive dyskinesia. In:
Schizophrenia and Aging: Schizophrenia, Paranoid and
Schizophreniform Disorders in Later Life. NE Miller and GD Cohen (eds).
New York: Guilford Press. pp. 275-286, 1987.
22. Weinberger DR, Jeste DV, Wyatt RJ and Teychenne PF: Cerebral
atrophy in elderly schizophrenic patients: Effects of aging and of
long-term institutionalization and neuroleptic therapy. In:
Schizophrenia and Aging: Schizophrenia, Paranoid and
Schizophreniform Disorders in Later Life. NE Miller and GD Cohen (eds).
New York: Guilford Press. pp 109-118, 1987.
23. Cadet JL, Lohr JB and Jeste DV: Tardive dyskinesia and
schizophrenic burnout: The possible involvement of cytotoxic free
radicals. In: Handbook of Schizophrenia. Vol. 2: The Neurochemistry
and Pharmacology of Schizophrenia. FA Henns and LE DeLisi (eds).
Amsterdam: Elsevier Science Publishers. Chapter 15, 1987.
24. Carpenter WT, Schooler NR, Goldman H, Goldstein MJ, Hogarty GE,
Jeste DV, Kane JM, Klerman GL, Liberman RP, Paul SM, Spring B, Stahl
SM, Tamminga CA, Robinson DS: Relieving the pain: Research on
treatment, services, and environmental factors. In: National
Institute of Mental Health: Report to the National Advisory Mental
Health Council on a National Plan for Research on Schizophrenia.
Washington, DC: US Department of Health and Human Services, 1987,
pp. 52-59.
25. Jeste DV, Harris MJ and Zweifach M: Late-onset schizophrenia.
In: Psychiatry, Revised edition. R Michels, JO Cavenar, Jr, NKH
Brodie, AM Cooper, SB Guze, LL Judd, GL Klerman, AJ Solnit (eds).
Philadelphia: JB Lippincott Co., 1988, Chapter 56, pp. 1-8.
26. Lohr, JB and Jeste, DV: Neuroleptic-induced movement disorders:
Acute and subacute disorders. In: Psychiatry, Revised edition. R
Michels, JO Cavenar, Jr, NKH Brodie, AM Cooper, SB Guze, LL Judd, GL
Klerman, AJ Solnit (eds). Philadelphia: JB Lippincott Co., 1988.
Chapter 69, pp. 1-19.
27. Lohr, JB and Jeste, DV: Neuroleptic-induced movement disorders:
Tardive dyskinesia and other tardive syndromes. In: Psychiatry,
Revised edition. R Michels, JO Cavenar, Jr, NKH Brodie, AM Cooper,
SB Guze, LL Judd, GL Klerman, AJ Solnit (eds). Philadelphia: JB
Lippincott Co., 1988. Chapter 70, pp. 1-17.
28. Gierz M, Zweifach M and Jeste DV: Antidepressant agents. In:
Alzheimer's Disease: Treatment and Long-term Management. JL Cummings
and BL Miller (eds). New York: Marcel Dekker, Inc, 1990, pp.
125-141.
29. Phillipson M, Moranville JT, Jeste DV and Harris MJ:
Antipsychotics. In: "Clinical Pharmacology" issue of "Clinics in
Geriatric Medicine" Peter P Lamy (ed). Philadelphia: WB Saunders
Company, 1990, pp 411-422.
30. Lohr JB, Manley MS, Kaufmann CA and Jeste DV: Neurochemistry.
In: Behavioral Sciences, Second Edition, JM Wiener (ed.). Baltimore:
Williams and Wilkins, 1990, pp. 1-21.
31. Jeste DV, Lohr JB and Kelsoe JM: Genetics of Behavioral
Disorders. In: Behavioral Sciences, Second Edition, JM Wiener (ed.).
Baltimore: Williams and Wilkins, 1990, pp. 57-70
32. Jeste DV: Neuroleptic treatment of chronically mentally ill
elderly: Suggestions for future research. In: The Elderly With
Mental Illness. E Light and B Lebowitz (eds). New York: Springer,
1991, pp. 133-144.
33. Sewell DD and Jeste DV: Neuroleptic Malignant Syndrome: Clinical
Presentation, Pathophysiology, and Treatment. In: Medical
Psychiatric Practice (Volume I). A Stoudemire and BS Fogel (eds).
Washington, DC: American Psychiatric Press, 1991, pp. 425-452.
34. Dupont RM and Jeste DV: Conclusion. In: Brain Imaging in
Affective Disorders. Hauser P (ed). Washington, DC: American
Psychiatric Press, Inc., 1991, pp. 137-142.
35. McAdams LA and Jeste DV: Statistical methods in studies of
chronically mentally ill elderly. In: The Elderly with Chronic
Mental Illness. E Light and B Lebowitz (eds). New York: Springer,
1991, pp. 321-333.
36. Yassa R, Uhr S and Jeste DV: Gender differences in chronic
schizophrenia: Need for further research. In: The Elderly with
Chronic Mental Illness. E Light and B Lebowitz (eds). New York:
Springer, 1991, pp. 16-31.
37. Jeste, DV, Manley, M and Harris, MJ: Psychoses. In:
Comprehensive Review of Geriatric Psychiatry. J Sadavoy, L Lazarus,
L Jarvik (eds). Washington, DC: American Psychiatric Press, 1991,
pp. 353-368.
38. Lohr JB, Jeste DV, Harris MJ and Salzman C: Treatment of
disordered behavior. In: Clinical Geriatric Psychopharmacology,
second edition. C Salzman (ed). Published by Williams and Wilkins,
1992, pp. 79-113.
39. Tran-Johnson TK, Krull AJ and Jeste DV: Late-life schizophrenia
and its treatment: pharmacologic issues in older schizophrenic
patients. In Clinics in Geriatric Medicine. GS Alexopoulos (ed).
Philadelphia, W.B. Saunders Company. 1992, pp. 401-410.
40. Jeste DV and Yassa R: Neuroleptic-induced Tardive Dyskinesia.
In: DSM-IV Sourcebook. Edited by Widiger TA, Francis AJ, Pincus HA,
First MB, Ross R, Davis W. Washington DC, American Psychiatric
Press, 1994, pp 573-582.
41. Tran-Johnson TK, Harris MJ and Jeste DV: Pharmacological
treatment of schizophrenia and delusional disorder of late life. In:
Principles and Practices of Geriatric Psychiatry. JRM Copeland, MT
Abou-Saleh, DG Blazer (eds). New York, John Wiley & Sons, 1994, pp
685-692.
42. Jeste DV, Manley MS, Manley LD and Lohr JB: Behavioral
neurochemistry, In: The Behavioral Sciences in Psychiatry, Third
edition. JF Wiener and NA Breslin (eds). Malvern, PA: Harwal
Publishing, 1995 pp. 3-23.
43. Breslin NA and Jeste DV: Genetics of Behavioral Disorders. In:
The Behavioral Sciences in Psychiatry, Third edition. JF Wiener and
NA Breslin (eds). Malvern, PA: Harwal Publishing, 1995 pp. 73-86.
44. Jeste DV, Paulsen J and Harris MJ: Late-onset schizophrenia and
other related psychoses. In: Psychopharmacology: The Fourth
Generation of Progress. FL Bloom, DJ Kupfer (eds). New York, NY:
Raven Press 1995 pp. 1437-1446.
45. Harris MJ and Jeste DV: Psychiatric disorders of late life:
Schizophrenia and delusional disorder. In: Comprehensive Textbook of
Psychiatry. Sixth Edition. HI Kaplan and BJ Sadock (eds). Baltimore:
Williams & Wilkins 1995 pp. 2569-2571.
46. Jeste DV, Naimark D, Halpain MC and Lindamer L: Strengths and
limitations of research in late-life psychoses. For: Emerging Issues
in Mental Health and Aging, (ed) Gatz M, American Psychological
Association, Washington DC. 1995 pp. 72-96.
47. Jeste DV, Gilbert PL, Kodsi A, Heaton SC, Lacro JP and Sewell
DD: Late-life schizophrenia. In: Schizophrenia. S. Hirsch and D.
Weinberger (eds). Blackwell Scientific, London, pp. 73-86, 1995.
48. Jeste DV: Place for Research in Biological Psychiatry in
Developing Countries. In: Methods in Biological Psychiatry. S.
Khanna, S.M. Channabasavanna and M.S. Keshavan (eds), Tata-McGraw
Hill, New Delhi, India, pp v-viii, 1995.
49. Halpain MC, Heaton SC, Warren KA, Lacro JP and Jeste DV: Health
Care Utilization Patterns in Late Life Schizophrenia: Case
Histories. In: Aging, Health, and Healing, edited by Bergener M.,
Brocklehurst J. and Finkel SI. New York: Springer Publishing
Company, Inc. 1995, p. 585 592.
50. Jeste DV, Harris MJ and Paulsen JS: Psychoses. In: Comprehensive
Review of Geriatric Psychiatry, Second edition. J Sadavoy, L
Lazarus, L Jarvik and G Grossberg (eds). Washington, DC: American
Psychiatric Press, 593-614, 1996.
51. Jeste DV, Galasko D, Corey-Bloom J, Walens S and Granholm E:
Neuropsychiatric aspects of the schizophrenias. In: Neuropsychiatry:
A Comprehensive Textbook. Fogel BS, Schiffer RB, Rao SM. Baltimore:
Williams & Wilkins. pp. 325-344,1996.
52. Jeste DV and Naimark D: Medication-induced movement disorders.
In: Psychiatry. A Tasman, J Lieberman, J Kay (eds.) Philadelphia:
W.B. Saunders Company, Vol 2., Chp. 69, pp. 1334-1354, 1996.
53. Magulac M and Jeste DV: Tardive dyskinesia in children and
adolescents. In: Neuroleptic-Induced Movement Disorders. R Yassa,
NVP Nair and DV Jeste (eds). London: Cambridge University Press. Chp
23, pp.311-337, 1996.
54. Lacro JP and Jeste DV: Role of ethnicity in the development of
tardive dyskinesia. In: Neuroleptic-Induced Movement Disorders. NPV
Nair, R Yassa and DV Jeste (eds). Chp 22, pp.298-310, 1996.
55. Jeste DV and Lebowitz BD: Coming of age. The Leifer Report,
Special Edition, pp. 39-40, 1997.
56. Jeste DV, Eastham JH, Gierz M, Field MG, Morgenstern M and Lacro
JP: F.J. Ayd, Jr. (ed). Use of risperidone in the elderly. In: The
Art of Rational Risperidone Therapy, AYD Medical Communications,
Baltimore, 1997, pp. 147-167.
57. Symonds LL and Jeste DV: Neuroimaging in late-life psychosis.
In: Brain Imaging in Clinical Psychiatry. Krishnan KRR and
Doraiswamy PM (eds) New York: Marcel Dekker, Inc, 1997, pp 425-448.
58. Eastham JH, Lacro JP, Lohr JB and Jeste DV: Treatment of
psychosis in late life. In: Geriatric Psychopharmacology. JC Nelson
(ed) New York: Marcel Dekker, Inc., Chp 17, pp 301-326, 1998.
59. Jeste DV, Eastham JH, Lohr JB and Salzman C: Diagnosis of
disordered behavior and psychosis. In: Clinical Geriatric
Psychopharmacology, 3rd edition. C Salzman (ed), Baltimore: Williams
& Wilkins, Ch. 5, 97-105, 1998.
60. Jeste DV, Eastham JH, Lohr JB and Salzman C: Treatment of
disordered behavior and psychosis. In: Clinical Geriatric
Psychopharmacology, 3rd edition. C Salzman (ed) Baltimore: Williams
& Wilkins, Ch. 6, 106-149, 1998.
61. Jeste DV and McClure FS: Psychoses: Diagnosis and treatment in
elderly. In: Updates in Geriatric Psychiatry, L. Schneider (ed),
Publisher: Jossey-Bass, Ch. 4, 53-70, 1998.
62. Salmon DP, Butters N, Thal L and Jeste DV: Alzheimer disease:
Data analysis for DSM-IV task force. In: DSM-IV Sourcebook, Vol IV.
Widiger TA, Frances HA, Pincus H, Ross R, First MB, Davis W, and
Kline M (eds) Washington, DC: American Psychiatric Press, 91-107,
1998.
63. Morris SK and Jeste DV: Schizophrenia and other psychotic
disorders. In: Principles of |
